Samsara (IOT) 10-Q 6 Dec 22 2023 Q3 Quarterly report Financial data

Cover

Cover - shares	9 Months Ended
	Oct. 29, 2022	Nov. 29, 2022
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Oct. 29, 2022
Document Transition Report	false
Entity File Number	001-41140
Entity Registrant Name	SAMSARA INC.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	47-3100039
Entity Address, Address Line One	1 De Haro Street
Entity Address, City or Town	San Francisco
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	94107
City Area Code	415
Local Phone Number	985-2400
Title of 12(b) Security	Class A Common Stock, $0.0001 par value per share
Trading Symbol	IOT
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Shell Company	false
Entity Central Index Key	0001642896
Amendment Flag	false
Current Fiscal Year End Date	--01-28
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	Q3
Common Class A
Cover [Abstract]
Entity Common Stock, Shares Outstanding		126,025,755
Common Class B
Cover [Abstract]
Entity Common Stock, Shares Outstanding		392,850,088
Common Class C
Cover [Abstract]
Entity Common Stock, Shares Outstanding		0

CONDENSED CONSOLIDATED BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Oct. 29, 2022	Jan. 29, 2022
Current assets:
Cash and cash equivalents	$ 447,040	$ 921,218
Short-term investments	291,815	0
Accounts receivable, net	90,796	81,987
Inventories	44,501	33,067
Connected device costs, current	72,685	52,519
Prepaid expenses and other current assets	16,196	11,376
Total current assets	963,033	1,100,167
Restricted cash	23,096	23,092
Long-term investments	63,688	0
Property and equipment, net	57,358	36,772
Operating lease right-of-use assets	118,511	134,427
Connected device costs, non-current	180,120	141,292
Deferred commissions	128,212	117,757
Other assets, non-current	15,964	14,422
Total assets	1,549,982	1,567,929
Current liabilities:
Accounts payable	43,366	54,705
Accrued expenses and other current liabilities	34,848	31,835
Accrued compensation and benefits	22,511	27,107
Deferred revenue, current	255,420	203,185
Operating lease liabilities, current	21,701	21,447
Total current liabilities	377,846	338,279
Deferred revenue, non-current	118,823	110,501
Operating lease liabilities, non-current	106,182	123,513
Other liabilities, non-current	7,378	6,689
Total liabilities	610,229	578,982
Commitments and contingencies (Note 9)
Stockholders’ equity:
Preferred stock, $0.0001 par value—400,000,000 shares authorized as of October 29, 2022 and January 29, 2022; zero shares issued and outstanding as of October 29, 2022 and January 29, 2022	0	0
Additional paid-in capital	2,055,481	1,909,964
Accumulated other comprehensive loss	(984)	(96)
Accumulated deficit	(1,114,774)	(920,950)
Total stockholders’ equity	939,753	988,947
Total liabilities and stockholders’ equity	1,549,982	1,567,929
Common Class A
Stockholders’ equity:
Common stock	7	6
Common Class B
Stockholders’ equity:
Common stock	23	23
Common Class C
Stockholders’ equity:
Common stock	$ 0	$ 0

CONDENSED CONSOLIDATED BALANC_2

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares	Oct. 29, 2022	Jan. 29, 2022
Preferred stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Preferred stock, authorized (in shares)	400,000,000	400,000,000
Preferred stock, issued (in shares)	0	0
Preferred stock, outstanding (in shares)	0	0
Common Class A
Common stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Common stock, authorized (in shares)	4,000,000,000	4,000,000,000
Common stock, issued (in shares)	125,399,546	77,144,718
Common stock, outstanding (in shares)	125,399,546	77,144,718
Common Class B
Common stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Common stock, authorized (in shares)	600,000,000	600,000,000
Common stock, issued (in shares)	393,473,497	428,331,442
Common stock, outstanding (in shares)	393,473,497	428,331,442
Common Class C
Common stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Common stock, authorized (in shares)	1,200,000,000	1,200,000,000
Common stock, issued (in shares)	0	0
Common stock, outstanding (in shares)	0	0

CONDENSED CONSOLIDATED STATEMEN

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 29, 2022	Oct. 30, 2021	Oct. 29, 2022	Oct. 30, 2021
Income Statement [Abstract]
Revenue	$ 169,800	$ 113,819	$ 465,968	$ 302,593
Cost of revenue	47,253	31,781	131,128	85,778
Gross profit	122,547	82,038	334,840	216,815
Operating expenses
Research and development	49,970	29,687	132,802	78,668
Sales and marketing	94,056	58,704	273,347	166,569
General and administrative	41,997	24,399	127,098	72,157
Lease modification, impairment, and related charges	0	1,532	1,056	1,532
Total operating expenses	186,023	114,322	534,303	318,926
Loss from operations	(63,476)	(32,284)	(199,463)	(102,111)
Interest income and other income (expense), net	5,613	(143)	7,094	241
Loss before provision for income taxes	(57,863)	(32,427)	(192,369)	(101,870)
Provision for income taxes	692	19	1,455	387
Net loss	(58,555)	(32,446)	(193,824)	(102,257)
Other comprehensive income (loss), net of taxes:
Change in foreign currency translation adjustment	315	46	416	46
Change in unrealized gains (losses) on investments	(1,304)	0	(1,304)	0
Other comprehensive income (loss)	(989)	46	(888)	46
Comprehensive loss	$ (59,544)	$ (32,400)	$ (194,712)	$ (102,211)
Basic and diluted net loss per share:
Net loss per share attributable to common stockholders, basic (in dollars per share)	$ (0.11)	$ (0.13)	$ (0.38)	$ (0.42)
Net loss per share attributable to common stockholders, diluted (in dollars per share)	$ (0.11)	$ (0.13)	$ (0.38)	$ (0.42)
Weighted-average shares used in computing net loss per share attributable to common stockholders, basic (in shares)	516,551,258	246,811,235	511,867,718	246,174,612
Weighted-average shares used in computing net loss per share attributable to common stockholders, diluted (in shares)	516,551,258	246,811,235	511,867,718	246,174,612

CONDENSED CONSOLIDATED STATEM_2

CONDENSED CONSOLIDATED STATEMENTS OF CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS’ EQUITY (DEFICIT) - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Accumulated Other Comprehensive Income (Loss)	Accumulated Deficit
Balance at beginning of period (in shares) at Jan. 30, 2021	205,638,256
Balance at beginning of period at Jan. 30, 2021	$ 949,067
Balance at end of period (in shares) at Oct. 30, 2021	205,638,256
Balance at end of period at Oct. 30, 2021	$ 949,067
Balance at beginning of period (in shares) at Jan. 30, 2021		245,985,471
Balance at beginning of period at Jan. 30, 2021	(532,803)	$ 1	$ 33,122	$ 0	$ (565,926)
Stockholders' Equity (Deficit)
Issuance of common stock under equity compensation plans (in shares)		2,335,940
Issuance of common stock under equity compensation plans	1,265	$ 1	1,264
Vesting of early exercised stock options	520		520
Repurchase of restricted common stock (in shares)		(8,266)
Repurchase of restricted common stock	(5)		(5)
Stock-based compensation expense	3,988		3,988
Other comprehensive income (loss)	46			46
Net loss	(102,257)				(102,257)
Balance at end of period (in shares) at Oct. 30, 2021		248,313,145
Balance at end of period at Oct. 30, 2021	$ (629,246)	$ 2	38,889	46	(668,183)
Balance at beginning of period (in shares) at Jul. 31, 2021	205,638,256
Balance at beginning of period at Jul. 31, 2021	$ 949,067
Balance at end of period (in shares) at Oct. 30, 2021	205,638,256
Balance at end of period at Oct. 30, 2021	$ 949,067
Balance at beginning of period (in shares) at Jul. 31, 2021		246,922,737
Balance at beginning of period at Jul. 31, 2021	(598,580)	$ 2	37,155	0	(635,737)
Stockholders' Equity (Deficit)
Issuance of common stock under equity compensation plans (in shares)		1,391,649
Issuance of common stock under equity compensation plans	376		376
Vesting of early exercised stock options	142		142
Repurchase of restricted common stock (in shares)		(1,241)
Repurchase of restricted common stock	(5)		(5)
Stock-based compensation expense	1,221		1,221
Other comprehensive income (loss)	46			46
Net loss	(32,446)				(32,446)
Balance at end of period (in shares) at Oct. 30, 2021		248,313,145
Balance at end of period at Oct. 30, 2021	$ (629,246)	$ 2	38,889	46	(668,183)
Balance at beginning of period (in shares) at Jan. 29, 2022	0
Balance at beginning of period at Jan. 29, 2022	$ 0
Balance at end of period (in shares) at Oct. 29, 2022	0
Balance at end of period at Oct. 29, 2022	$ 0
Balance at beginning of period (in shares) at Jan. 29, 2022		505,476,160
Balance at beginning of period at Jan. 29, 2022	988,947	$ 29	1,909,964	(96)	(920,950)
Stockholders' Equity (Deficit)
Issuance of common stock for vesting of restricted stock units (“RSUs”) (in shares)		10,711,083
Issuance of common stock for vesting of restricted stock units (“RSUs”)	1	$ 1
Issuance of common stock under equity compensation plans (in shares)		2,686,238
Issuance of common stock under equity compensation plans	10,877		10,877
Vesting of early exercised stock options	253		253
Repurchase of restricted common stock (in shares)		(438)
Stock-based compensation expense	134,387		134,387
Other comprehensive income (loss)	(888)			(888)
Net loss	(193,824)				(193,824)
Balance at end of period (in shares) at Oct. 29, 2022		518,873,043
Balance at end of period at Oct. 29, 2022	$ 939,753	$ 30	2,055,481	(984)	(1,114,774)
Balance at beginning of period (in shares) at Jul. 30, 2022	0
Balance at beginning of period at Jul. 30, 2022	$ 0
Balance at end of period (in shares) at Oct. 29, 2022	0
Balance at end of period at Oct. 29, 2022	$ 0
Balance at beginning of period (in shares) at Jul. 30, 2022		514,366,270
Balance at beginning of period at Jul. 30, 2022	953,138	$ 29	2,009,323	5	(1,056,219)
Stockholders' Equity (Deficit)
Issuance of common stock for vesting of restricted stock units (“RSUs”) (in shares)		4,219,328
Issuance of common stock for vesting of restricted stock units (“RSUs”)	1	$ 1
Issuance of common stock under equity compensation plans (in shares)		287,445
Issuance of common stock under equity compensation plans	165		165
Vesting of early exercised stock options	75		75
Stock-based compensation expense	45,918		45,918
Other comprehensive income (loss)	(989)			(989)
Net loss	(58,555)				(58,555)
Balance at end of period (in shares) at Oct. 29, 2022		518,873,043
Balance at end of period at Oct. 29, 2022	$ 939,753	$ 30	$ 2,055,481	$ (984)	$ (1,114,774)

CONDENSED CONSOLIDATED STATEM_3

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	9 Months Ended
	Oct. 29, 2022	Oct. 30, 2021
Operating activities
Net loss	$ (193,824)	$ (102,257)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	8,350	8,217
Stock-based compensation expense	133,490	3,988
Lease modification, impairment, and related charges	1,056	1,532
Other non-cash charges	3,336	5,428
Changes in operating assets and liabilities:
Accounts receivable, net	(13,297)	(23,685)
Inventories	(11,434)	(8,635)
Prepaid expenses and other current assets	(5,300)	(1,819)
Connected device costs	(58,993)	(62,433)
Deferred commissions	(10,455)	(14,770)
Other assets, non-current	(1,520)	(939)
Accounts payable and other liabilities	(9,398)	35,468
Deferred revenue	60,557	36,825
Operating lease liabilities, net	(1,216)	(96)
Net cash used in operating activities	(98,648)	(123,176)
Investing activities
Purchase of property and equipment	(27,237)	(9,953)
Purchases of investments	(355,730)	0
Investing other	432	(582)
Net cash used in investing activities	(382,535)	(10,535)
Financing activities
Proceeds from issuance of common stock in connection with equity compensation plans	10,868	965
Proceeds from early exercise of stock options	0	152
Repurchase of restricted common stock	0	(5)
Payment of offering costs	(2,532)	(2,160)
Payment of principal on finance leases	(856)	(336)
Net cash provided by (used in) financing activities	7,480	(1,384)
Effect of foreign exchange rate changes on cash, cash equivalents, and restricted cash	(471)	46
Net decrease in cash, cash equivalents, and restricted cash	(474,174)	(135,049)
Cash, cash equivalents, and restricted cash, beginning of period	944,310	434,309
Cash, cash equivalents, and restricted cash, end of period	470,136	299,260
Supplemental disclosure of cash flow information:
Cash paid for income taxes	315	168
Supplemental disclosures of non-cash investing and financing activities:
Property and equipment accrued but not yet paid	1,081	1,254
Stock option exercises in transit	1	122
Unpaid offering costs	0	935
Vesting of early exercised stock options	$ 253	$ 520

Description of Business

Description of Business	9 Months Ended
	Oct. 29, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Description of Business	Description of BusinessSamsara Inc. (“Samsara”) and its subsidiaries (collectively, the “Company”) are the pioneers of the Connected Operations Cloud, which allows businesses that depend on physical operations to harness Internet of Things (“IoT”) data to develop actionable business insights and improve their operations. Samsara was incorporated in Delaware in 2015 as Samsara Networks Inc. and changed its name to Samsara Inc. in February 2021. Samsara’s principal executive offices are located at 1 De Haro Street, San Francisco, California 94107.

Summary of Significant Accounti

Summary of Significant Accounting Policies	9 Months Ended
	Oct. 29, 2022
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Summary of Significant Accounting Policies Basis of Presentation and Fiscal Year —The accompanying unaudited condensed consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”) and applicable rules and regulations of the U.S. Securities and Exchange Commission (“SEC”) regarding interim financial reporting. Accordingly, they do not include all disclosures normally required in annual consolidated financial statements prepared in accordance with GAAP. Therefore, these unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes included in the Company’s Annual Report on Form 10-K for the fiscal year ended January 29, 2022, which was filed with the SEC on March 30, 2022. In management’s opinion, these unaudited condensed consolidated financial statements have been prepared on the same basis as the annual financial statements and reflect all adjustments, which include only normal recurring adjustments necessary for the fair statement of the Company’s financial position as of October 29, 2022 and the results of operations for the three and nine months ended October 29, 2022 and October 30, 2021, and cash flows for the nine months ended October 29, 2022 and October 30, 2021. The condensed consolidated balance sheet as of January 29, 2022 was derived from the audited financial statements but does not include all disclosures required by GAAP. The results of operations for the three and nine months ended October 29, 2022 are not necessarily indicative of the results to be expected for the full year or any other future interim or annual period. The Company’s fiscal year is a 52- or 53-week period ending on the Saturday closest to February 1. Fiscal year 2023 consists of 52 weeks and fiscal year 2022 consisted of 52 weeks. Every sixth fiscal year is a 53-week year. Fiscal year 2024 is the Company’s next 53-week fiscal year, with the fourth quarter consisting of 14 weeks. Principles of Consolidation —The condensed consolidated financial statements include the accounts of Samsara and its wholly owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation. Use of Estimates —The preparation of condensed consolidated financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and accompanying notes. Such management estimates include, but are not limited to, the fair value of stock-based awards, internal-use software development costs, sales return reserve, accrued liabilities and contingencies, depreciation and amortization periods, lease modification, impairment, and related charges, and accounting for income taxes. Actual results could materially differ from the estimates and assumptions made. Significant Accounting Policies —There were no material changes to the Company’s significant accounting policies during the nine months ended October 29, 2022, except for the addition of the accounting policy for the Company’s investments. Investments —The Company’s investments in marketable debt securities have been classified and accounted for as available-for-sale and are recorded at estimated fair value. The Company determines the appropriate classification of investments at the time of purchase and reevaluates such determination at each balance sheet date and classifies its marketable debt securities as either short-term or long-term based on their remaining contractual maturities. Short-term investments are investments with original or remaining maturities of one year or less at each balance sheet date. Purchase premiums and discounts are amortized or accreted using the effective interest method over the life of the related security and such amortization and accretion are included in “Interest income and other income (expense), net” on the condensed consolidated statements of operations and comprehensive loss. For available-for-sale securities in an unrealized loss position, the Company first assesses whether it intends to sell or it is more likely than not that the Company will be required to sell the security before the recovery of its entire amortized cost basis. If either of these criteria is met, the security’s amortized cost basis is written down to fair value through “Interest income and other income (expense), net” on the condensed consolidated statements of operations and comprehensive loss. If neither of these criteria is met, the Company further assesses whether the decline in fair value below amortized cost is due to credit or non-credit related factors. In making this assessment, the Company considers the extent to which fair value is less than amortized cost, any changes to the rating of the security by a rating agency, and any adverse conditions specifically related to the security, among other factors. Credit-related unrealized losses are recognized as an allowance on the condensed consolidated balance sheets with a corresponding charge in “Interest income and other income (expense), net” on the condensed consolidated statements of operations and comprehensive loss. Non-credit related unrealized losses and unrealized gains on available-for-sale securities are included in accumulated other comprehensive income (loss). Realized gains and losses are determined based on the specific identification method and are reported in “Interest income and other income (expense), net” on the condensed consolidated statements of operations and comprehensive loss. See Note 4, “Fair Value Measurements,” for information regarding the fair value of the Company’s investments in marketable debt securities. Recently Adopted Accounting Pronouncements —There were no new accounting pronouncements adopted during the nine months ended October 29, 2022. Recent Accounting Pronouncements Not Yet Adopted —In June 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2016-13, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments . This standard changes the methodology for measuring credit losses on financial instruments and the timing of when such losses are recorded. In April 2019, the FASB issued ASU No. 2019-04, Codification Improvements to Topic 326, Financial Instruments—Credit Losses, Topic 815 , Derivatives and Hedging, and Topic 825, Financial Instruments . The amendments in this update represent changes to clarify, correct errors in, or improve the codification. In May 2019, the FASB issued ASU No. 2019-05, Financial Instruments—Credit Losses (Topic 326) . The amendments in this update provide entities that have certain instruments within the scope of Subtopic 326-20, Financial Instruments—Credit Losses—Measured at Amortized Cost , with an option to irrevocably elect the fair value option in Subtopic 825-10, Financial Instruments—Overall , applied on an instrument-by-instrument basis for eligible instruments, upon adoption of Topic 326. This guidance is effective for the Company for its fiscal year beginning January 29, 2023. The standard requires a modified retrospective method of adoption. This new standard is not expected to have a material impact on the Company’s consolidated financial statements. The Company has reviewed all other recently issued accounting pronouncements and concluded they were either not applicable or not expected to have a material impact on the Company’s consolidated financial statements.

Cash, Cash Equivalents, Restric

Cash, Cash Equivalents, Restricted Cash, and Investments	9 Months Ended
	Oct. 29, 2022
Cash and Cash Equivalents [Abstract]
Cash, Cash Equivalents, Restricted Cash, and Investments	Cash, Cash Equivalents, Restricted Cash, and Investments As of October 29, 2022 and January 29, 2022, cash and cash equivalents consist of cash deposited with banks and money market funds, and all highly liquid investments with an original or remaining maturity of three months or less when purchased. As of October 29, 2022, short-term and long-term investments in marketable debt securities consist of U.S. government and agency securities, corporate notes and bonds, commercial paper, and money market funds. Restricted cash as of October 29, 2022 and January 29, 2022 consists of letters of credit secured as collateral on the Company’s office space leases. Total cash, cash equivalents, and restricted cash consist of the following (in thousands): As of October 29, 2022 January 29, 2022 Cash and cash equivalents $ 447,040 $ 921,218 Restricted cash 23,096 23,092 Total cash, cash equivalents, and restricted cash $ 470,136 $ 944,310 The following is a summary of the Company’s cash equivalents and available-for-sale marketable debt securities recorded within short-term and long-term investments on the condensed consolidated balance sheets (in thousands): As of October 29, 2022 Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Estimated Fair Value Cash equivalents: Money market funds $ 37,282 $ — $ — $ 37,282 Commercial paper 211,820 — (18) 211,802 U.S. government and agency securities 41,893 1 (14) 41,880 Corporate notes and bonds 4,998 — (4) 4,994 Total cash equivalents $ 295,993 $ 1 $ (36) $ 295,958 Investments: Commercial paper 134,467 — (14) 134,453 Corporate notes and bonds 112,757 5 (605) 112,157 U.S. government and agency securities $ 109,548 $ 6 $ (661) $ 108,893 Total investments $ 356,772 $ 11 $ (1,280) $ 355,503 The Company included $1.0 million of interest receivable in “Prepaid expenses and other current assets” on the condensed consolidated balance sheets as of October 29, 2022. For available-for-sale marketable debt securities with unrealized loss positions, the Company does not intend to sell any of the securities and the Company considers it more likely than not that the Company will hold these securities until a recovery of the cost basis, which may not occur until maturity. The Company did not recognize an allowance for credit losses on these securities as of October 29, 2022 because such potential losses were not material. As of October 29, 2022, the contractual maturities of the Company’s investments did not exceed 24 months. The estimated fair values of available-for-sale marketable debt securities, by remaining contractual maturity, are as follows (in thousands): As of October 29, 2022 Due within one year $ 291,815 Due in one year to two years 63,688 Total $ 355,503 There were no material realized or unrealized gains or losses, either individually or in the aggregate, during the three and nine months ended October 29, 2022. Concentrations of Credit Risk —The Company maintains its investments in marketable debt securities with high-quality financial institutions with investment-grade ratings.

Fair Value Measurements

Fair Value Measurements	9 Months Ended
	Oct. 29, 2022
Fair Value Disclosures [Abstract]
Fair Value Measurements	Fair Value Measurements The Company reports all financial assets and liabilities and nonfinancial assets and liabilities that are recognized or disclosed at fair value in the condensed consolidated financial statements on a recurring basis. The authoritative guidance establishes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to measurements involving significant unobservable inputs (Level 3 measurements). The three levels of the fair value hierarchy are as follows: Level 1 —Observable inputs that reflect quoted prices (unadjusted) in active markets for identical assets or liabilities. Level 2 —Observable inputs other than quoted prices in active markets for identical assets or liabilities, quoted prices for identical or similar assets or liabilities in inactive markets, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. Level 3 —Inputs that are generally unobservable and typically reflect management’s estimates of assumptions that market participants would use in pricing the asset or liability. The level in the fair value hierarchy within which a fair value measurement in its entirety falls is based on the lowest-level input that is significant to the fair value measurement in its entirety. The condensed consolidated financial statements as of October 29, 2022 and January 29, 2022 do not include any nonrecurring fair value measurements relating to assets or liabilities. The following tables present the fair value hierarchy for the Company’s assets measured at fair value on a recurring basis as of the periods presented (in thousands): As of October 29, 2022 Level 1 Level 2 Level 3 Total Cash equivalents and restricted cash: Cash equivalents Money market funds $ 160,378 $ — $ — $ 160,378 Commercial paper — 211,802 — 211,802 U.S. government and agency securities — 41,880 — 41,880 Corporate notes and bonds — 4,994 — 4,994 Restricted cash—letters of credit 23,096 — — 23,096 Total cash equivalents and restricted cash $ 183,474 $ 258,676 $ — $ 442,150 Marketable debt securities: Commercial paper $ — $ 134,453 $ — $ 134,453 Corporate notes and bonds — 112,157 — 112,157 U.S. government and agency securities — 108,893 — 108,893 Total marketable debt securities $ — $ 355,503 $ — $ 355,503 As of January 29, 2022 Level 1 Level 2 Level 3 Total Cash equivalents—money market funds $ 866,364 $ — $ — $ 866,364 Restricted cash—letters of credit 23,092 — — 23,092 Total cash equivalents and restricted cash $ 889,456 $ — $ — $ 889,456 The Company determines the fair value of its security holdings based on pricing from the Company’s service providers and market prices from industry-standard independent data providers. Such market prices may be quoted prices in active markets for identical assets (Level 1 inputs) or pricing determined using inputs other than quoted prices that are observable either directly or indirectly (Level 2 inputs), such as yield curve, volatility factors, credit spreads, default rates, loss severity, current market and contractual prices for the underlying instruments or debt, broker and dealer quotes, as well as other relevant economic measures. There were no transfers between Level 1 or Level 2, or transfers in or out of Level 3 of the fair value hierarchy during the nine months ended October 29, 2022 and October 30, 2021.

Costs to Obtain and Fulfill a C

Costs to Obtain and Fulfill a Contract	9 Months Ended
	Oct. 29, 2022
Revenue from Contract with Customer [Abstract]
Costs to Obtain and Fulfill a Contract	Costs to Obtain and Fulfill a Contract Deferred Commissions —Total deferred commissions as of October 29, 2022 and January 29, 2022 was $128.2 million and $117.8 million, respectively. The following table provides the amounts capitalized and amortized for the Company’s commission costs for the periods presented (in thousands): Three Months Ended Nine Months Ended October 29, 2022 October 30, 2021 October 29, 2022 October 30, 2021 Capitalized commission costs $ 16,599 $ 17,401 $ 47,442 $ 48,979 Amortization expense 12,477 11,982 36,987 34,210 Connected Devices —Total connected device costs, which the Company also refers to as IoT device costs, current and non-current as of October 29, 2022 and January 29, 2022 was $252.8 million and $193.8 million, respectively. The following table provides the amounts capitalized and amortized for the Company’s connected device costs for the periods presented (in thousands): Three Months Ended Nine Months Ended October 29, 2022 October 30, 2021 October 29, 2022 October 30, 2021 Capitalized connected device costs $ 39,244 $ 31,051 $ 105,014 $ 89,979 Amortization expense 17,048 10,672 46,020 27,545 Revenue Recognition —Subscription revenue is generated from subscriptions to access the Company’s Connected Operations Cloud. Subscription agreements contain multiple service elements for one or more of the Company’s cloud-based Applications via mobile app(s) or a website that enable data collection and provide access to the cellular network, generally one or more wireless gateways, cameras, sensors and other devices (collectively, “connected devices” or “IoT devices”), support services delivered over the term of the arrangement and warranty coverage. The Company’s Connected Operations Cloud and the related connected device access points are highly interdependent and interrelated, and represent a combined performance obligation, which is recognized over the related subscription period. Other revenue is generally recognized at a point in time and is earned through the sale of replacement gateways, sensors and cameras, as well as related shipping and handling fees, credit card processing fees, and professional services. Revenue consists of the following (in thousands): Three Months Ended Nine Months Ended October 29, 2022 October 30, 2021 October 29, 2022 October 30, 2021 Subscription revenue $ 166,555 $ 108,981 $ 457,083 $ 294,743 Other revenue 3,245 4,838 8,885 7,850 Total revenue $ 169,800 $ 113,819 $ 465,968 $ 302,593 Deferred Revenue —The following table provides the deferred revenue balances and revenue recognized from beginning deferred revenue balances for the periods presented (in thousands): Three Months Ended Nine Months Ended October 29, 2022 October 30, 2021 October 29, 2022 October 30, 2021 Deferred revenue, beginning of period $ 354,570 $ 274,332 $ 313,686 $ 249,572 Deferred revenue, end of period 374,243 286,509 374,243 286,509 Revenue recognized in the period from beginning deferred revenue balance 156,716 116,586 188,197 127,068 Remaining Performance Obligations (“RPO”) —RPO represents the amount of contracted future revenue that has not yet been recognized, including both deferred revenue and non-cancelable contracted amounts that will be invoiced and recognized as revenue in future periods. As of October 29, 2022, the Company’s RPO was $1,290.8 million. The Company expects to recognize revenue of approximately $631.3 million over the next 12 months, with the remaining balance recognized thereafter. Concentrations of Significant Customers and Credit Risk —No customer accounted for greater than 10% of the Company’s total revenue for the three and nine months ended October 29, 2022 and October 30, 2021. There were no customers that individually represented greater than 10% of the Company’s accounts receivable as of October 29, 2022 and January 29, 2022.

Property and Equipment, Net

Property and Equipment, Net	9 Months Ended
	Oct. 29, 2022
Property, Plant and Equipment [Abstract]
Property and Equipment, Net	Property and Equipment, Net Property and equipment, net, comprises the following (in thousands): As of October 29, 2022 January 29, 2022 Gross property and equipment Computers and equipment $ 1,206 $ 834 Leasehold improvements 45,982 24,752 Furniture and fixtures 19,765 16,854 Internal-use software development costs (1) 20,706 16,152 Total gross property and equipment 87,659 58,592 Accumulated depreciation and amortization (2) (30,301) (21,820) Property and equipment, net $ 57,358 $ 36,772 __________ (1) The Company’s internal-use software development costs included $0.5 million and $1.1 million of stock-based compensation costs for the three and nine months ended October 29, 2022, respectively, and an immaterial amount of stock-based compensation costs for the three and nine months ended October 30, 2021. The following table provides the amounts capitalized and amortized for the Company’s internal-use software development costs for the periods presented (in thousands): Three Months Ended Nine Months Ended October 29, 2022 October 30, 2021 October 29, 2022 October 30, 2021 Capitalized internal-use software development costs $ 2,003 $ 1,310 $ 4,554 $ 3,226 Amortization expense $ 934 $ 856 $ 2,911 $ 2,398 Internal-use software development costs, net, as of the periods presented was as follows (in thousands): As of October 29, 2022 January 29, 2022 Internal-use software development costs, net $ 8,168 $ 6,747 (2) The following table presents the depreciation and amortization of property and equipment, excluding the accelerated depreciation expense of $29.7 million recorded in connection with the lease modification during the three and nine months ended October 30, 2021, which is included in “Lease modification, impairment, and related charges” on the Company’s condensed consolidated statements of operations and comprehensive loss (in thousands): Three Months Ended Nine Months Ended October 29, 2022 October 30, 2021 October 29, 2022 October 30, 2021 Depreciation and amortization expense $ 3,345 $ 512 $ 8,350 $ 5,819

Leases

Leases	9 Months Ended
	Oct. 29, 2022
Leases [Abstract]
Leases	Leases The Company leases office space under operating lease agreements that are non-cancelable (subject to limited termination rights). These leases have remaining lease terms ranging from one year to 10 years. The Company is required to pay property taxes, insurance, and normal maintenance costs for certain of these facilities, and will be required to pay any increases over the base year of these expenses on the remainder of the Company’s facilities. The Company impaired and ceased using leased office spaces for which the Company recorded $1.1 million of expense in “Lease modification, impairment, and related charges” for the nine months ended October 29, 2022. The components of operating lease expense were as follows (in thousands): Three Months Ended Nine Months Ended October 29, 2022 October 30, 2021 October 29, 2022 October 30, 2021 Operating lease cost $ 6,333 $ 6,146 $ 19,096 $ 17,686 Short-term lease cost 172 45 486 157 Sublease income (195) (75) (581) (75) Total lease cost $ 6,310 $ 6,116 $ 19,001 $ 17,768 Supplemental information related to operating leases was as follows (in thousands, except for weighted-average data): Three Months Ended Nine Months Ended October 29, 2022 October 30, 2021 October 29, 2022 October 30, 2021 Cash paid for amounts in the measurement of operating lease liabilities—operating cash flows $ 6,725 $ 8,418 $ 20,017 $ 18,856 Operating lease ROU assets obtained in exchange for new operating lease liabilities $ — $ 19,135 $ — $ 19,135 In the second quarter of fiscal year 2023, the Company relocated from its former corporate headquarters to its new corporate headquarters. During the nine months ended October 29, 2022, the Company recorded no additional operating leases and had a reduction of right-of-use (“ROU”) assets associated with a lease impairment of $1.0 million. As of October 29, 2022 January 29, 2022 Weighted-average remaining lease term—operating leases (in years) 6.6 7.1 Weighted-average discount rate—operating leases 4.49 % 4.38 % Future minimum lease payments included in the measurement of operating lease liabilities as of October 29, 2022 were as follows (in thousands): Fiscal Years Ending Amount Remainder of 2023 $ 6,772 2024 26,853 2025 26,850 2026 19,946 2027 14,236 2028 and thereafter 56,239 Total future minimum lease payments (1) 150,896 Less: imputed interest (23,013) Total operating lease liabilities $ 127,883 __________ (1) The contractual commitment amounts under operating leases in the table above are primarily related to facility leases for the Company’s corporate office facilities in San Francisco, California, which was completed in the second quarter of fiscal year 2023, as well as other offices for the Company’s local operations. The table above does not reflect obligations under contracts that the Company can cancel without a significant penalty, the Company’s option to exercise early termination rights, or the payment of related early termination fees. In addition to its operating leases, the Company has entered into non-cancelable finance leases for equipment beginning in 2020. The balances for finance leases were recorded in “ Other assets, non-current, Accrued expenses and other current liabilities Other liabilities, non-current
Leases	Leases The Company leases office space under operating lease agreements that are non-cancelable (subject to limited termination rights). These leases have remaining lease terms ranging from one year to 10 years. The Company is required to pay property taxes, insurance, and normal maintenance costs for certain of these facilities, and will be required to pay any increases over the base year of these expenses on the remainder of the Company’s facilities. The Company impaired and ceased using leased office spaces for which the Company recorded $1.1 million of expense in “Lease modification, impairment, and related charges” for the nine months ended October 29, 2022. The components of operating lease expense were as follows (in thousands): Three Months Ended Nine Months Ended October 29, 2022 October 30, 2021 October 29, 2022 October 30, 2021 Operating lease cost $ 6,333 $ 6,146 $ 19,096 $ 17,686 Short-term lease cost 172 45 486 157 Sublease income (195) (75) (581) (75) Total lease cost $ 6,310 $ 6,116 $ 19,001 $ 17,768 Supplemental information related to operating leases was as follows (in thousands, except for weighted-average data): Three Months Ended Nine Months Ended October 29, 2022 October 30, 2021 October 29, 2022 October 30, 2021 Cash paid for amounts in the measurement of operating lease liabilities—operating cash flows $ 6,725 $ 8,418 $ 20,017 $ 18,856 Operating lease ROU assets obtained in exchange for new operating lease liabilities $ — $ 19,135 $ — $ 19,135 In the second quarter of fiscal year 2023, the Company relocated from its former corporate headquarters to its new corporate headquarters. During the nine months ended October 29, 2022, the Company recorded no additional operating leases and had a reduction of right-of-use (“ROU”) assets associated with a lease impairment of $1.0 million. As of October 29, 2022 January 29, 2022 Weighted-average remaining lease term—operating leases (in years) 6.6 7.1 Weighted-average discount rate—operating leases 4.49 % 4.38 % Future minimum lease payments included in the measurement of operating lease liabilities as of October 29, 2022 were as follows (in thousands): Fiscal Years Ending Amount Remainder of 2023 $ 6,772 2024 26,853 2025 26,850 2026 19,946 2027 14,236 2028 and thereafter 56,239 Total future minimum lease payments (1) 150,896 Less: imputed interest (23,013) Total operating lease liabilities $ 127,883 __________ (1) The contractual commitment amounts under operating leases in the table above are primarily related to facility leases for the Company’s corporate office facilities in San Francisco, California, which was completed in the second quarter of fiscal year 2023, as well as other offices for the Company’s local operations. The table above does not reflect obligations under contracts that the Company can cancel without a significant penalty, the Company’s option to exercise early termination rights, or the payment of related early termination fees. In addition to its operating leases, the Company has entered into non-cancelable finance leases for equipment beginning in 2020. The balances for finance leases were recorded in “ Other assets, non-current, Accrued expenses and other current liabilities Other liabilities, non-current

Deferred Revenue and Remaining

Deferred Revenue and Remaining Performance Obligations	9 Months Ended
	Oct. 29, 2022
Revenue from Contract with Customer [Abstract]
Deferred Revenue and Remaining Performance Obligations	Costs to Obtain and Fulfill a Contract Deferred Commissions —Total deferred commissions as of October 29, 2022 and January 29, 2022 was $128.2 million and $117.8 million, respectively. The following table provides the amounts capitalized and amortized for the Company’s commission costs for the periods presented (in thousands): Three Months Ended Nine Months Ended October 29, 2022 October 30, 2021 October 29, 2022 October 30, 2021 Capitalized commission costs $ 16,599 $ 17,401 $ 47,442 $ 48,979 Amortization expense 12,477 11,982 36,987 34,210 Connected Devices —Total connected device costs, which the Company also refers to as IoT device costs, current and non-current as of October 29, 2022 and January 29, 2022 was $252.8 million and $193.8 million, respectively. The following table provides the amounts capitalized and amortized for the Company’s connected device costs for the periods presented (in thousands): Three Months Ended Nine Months Ended October 29, 2022 October 30, 2021 October 29, 2022 October 30, 2021 Capitalized connected device costs $ 39,244 $ 31,051 $ 105,014 $ 89,979 Amortization expense 17,048 10,672 46,020 27,545 Revenue Recognition —Subscription revenue is generated from subscriptions to access the Company’s Connected Operations Cloud. Subscription agreements contain multiple service elements for one or more of the Company’s cloud-based Applications via mobile app(s) or a website that enable data collection and provide access to the cellular network, generally one or more wireless gateways, cameras, sensors and other devices (collectively, “connected devices” or “IoT devices”), support services delivered over the term of the arrangement and warranty coverage. The Company’s Connected Operations Cloud and the related connected device access points are highly interdependent and interrelated, and represent a combined performance obligation, which is recognized over the related subscription period. Other revenue is generally recognized at a point in time and is earned through the sale of replacement gateways, sensors and cameras, as well as related shipping and handling fees, credit card processing fees, and professional services. Revenue consists of the following (in thousands): Three Months Ended Nine Months Ended October 29, 2022 October 30, 2021 October 29, 2022 October 30, 2021 Subscription revenue $ 166,555 $ 108,981 $ 457,083 $ 294,743 Other revenue 3,245 4,838 8,885 7,850 Total revenue $ 169,800 $ 113,819 $ 465,968 $ 302,593 Deferred Revenue —The following table provides the deferred revenue balances and revenue recognized from beginning deferred revenue balances for the periods presented (in thousands): Three Months Ended Nine Months Ended October 29, 2022 October 30, 2021 October 29, 2022 October 30, 2021 Deferred revenue, beginning of period $ 354,570 $ 274,332 $ 313,686 $ 249,572 Deferred revenue, end of period 374,243 286,509 374,243 286,509 Revenue recognized in the period from beginning deferred revenue balance 156,716 116,586 188,197 127,068 Remaining Performance Obligations (“RPO”) —RPO represents the amount of contracted future revenue that has not yet been recognized, including both deferred revenue and non-cancelable contracted amounts that will be invoiced and recognized as revenue in future periods. As of October 29, 2022, the Company’s RPO was $1,290.8 million. The Company expects to recognize revenue of approximately $631.3 million over the next 12 months, with the remaining balance recognized thereafter. Concentrations of Significant Customers and Credit Risk —No customer accounted for greater than 10% of the Company’s total revenue for the three and nine months ended October 29, 2022 and October 30, 2021. There were no customers that individually represented greater than 10% of the Company’s accounts receivable as of October 29, 2022 and January 29, 2022.

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
	Oct. 29, 2022
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies Operating Leases —See Note 7, “Leases,” for the maturities of operating lease liabilities as of October 29, 2022. Purchase Commitments —The Company’s purchase commitments consist of contractual arrangements with software-as-a-service subscription providers and non-cancelable purchase orders based on current inventory needs fulfilled by its suppliers and contract manufacturers. In June 2022, the Company amended its agreement with a third-party cloud infrastructure provider and committed to spend at least $275.0 million between July 2022 and June 2027 on cloud infrastructure services ($33.0 million between July 2022 and June 2023, $42.0 million between July 2023 and June 2024, $52.0 million between July 2024 and June 2025, $66.0 million between July 2025 and June 2026, and $82.0 million between July 2026 and June 2027). The commitment may be offset by up to $11.0 million in additional credits subject to the Company meeting certain conditions of the agreement, of which $0.3 million had been earned as of October 29, 2022. Letters of Credit —As of October 29, 2022 and January 29, 2022, the Company had $23.1 million and $23.1 million, respectively, in letters of credit outstanding in favor of certain landlords for office space. These letters of credit renew annually and expire on various dates through 2031. Litigation —From time to time, the Company may become involved in various legal proceedings in the ordinary course of its business and may be subject to third-party intellectual property infringement claims. The Company continually evaluates uncertainties associated with litigation and records a charge equal to at least the minimum estimated liability for a loss contingency when both of the following conditions are met: (i) information available prior to issuance of the condensed consolidated financial statements indicates that it is probable that a liability has been incurred at the date of the condensed consolidated financial statements and (ii) the loss or range of loss can be reasonably estimated. If the Company determines that a loss is possible and a range of the loss can be reasonably estimated, the Company will disclose the range of the possible loss. The Company evaluates developments in legal matters that could affect the amount of liability that has been previously accrued, if any, and the matters and related ranges of possible losses disclosed and makes adjustments and changes to the disclosures, as appropriate. Significant judgment is required to determine both likelihood of there being, and the estimated amount of, a loss related to such matters. Until the final resolution of such matters, there may be an exposure to loss, and such amounts could be material. For legal proceedings for which there is a reasonable possibility of loss (meaning those losses for which the likelihood is more than remote but less than probable), the Company has determined there is no material exposure on an aggregate basis. The amounts recorded for losses deemed probable as of October 29, 2022 were also not material. Lease-Related Litigation —In March 2019, the Company signed a lease agreement with a landlord for certain premises located in San Francisco, California (the “Premises”). In September 2021, the Company sued the landlord in San Francisco Superior Court to enforce its right to terminate the lease and to recover damages on the grounds that the Premises were never adequately delivered to the Company. The landlord countersued the Company for allegedly breaching the lease. On October 30, 2021, the Company vacated the Premises. On November 17, 2021, the landlord drew down the remaining $8.7 million letter of credit, which the Company accounts for as a receivable in “Other assets, non-current.” The outcome of this matter is subject to ongoing litigation and is uncertain at this time. Indemnification —In the normal course of business, the Company may agree to indemnify third parties with whom it enters into contractual relationships, including customers, lessors, and parties, to other transactions with the Company, with respect to certain matters. The Company has agreed, under certain conditions, to hold these third parties harmless against specified losses, such as those arising from a breach of representations or covenants, or claims that the Company’s products infringe the intellectual property rights of other parties, or other claims made against certain parties. It is not possible to determine the maximum potential amount of liability under these indemnification obligations due to the Company’s limited history of prior indemnification claims and the unique facts and circumstances that are likely to be involved in each particular claim.

Equity

Equity	9 Months Ended
	Oct. 29, 2022
Equity [Abstract]
Equity	Equity As of October 29, 2022, there were 125,399,546, 393,473,497, and no shares of Class A, Class B, and Class C common stock issued and outstanding, respectively. As of January 29, 2022, there were 77,144,718, 428,331,442, and no shares of Class A, Class B, and Class C common stock issued and outstanding, respectively. The Company had reserved shares of common stock for future issuance as of October 29, 2022 and January 29, 2022, as follows: As of October 29, 2022 January 29, 2022 2015 Equity Incentive Plan: Options outstanding 7,045,765 8,628,071 RSUs outstanding 17,768,415 29,452,103 2021 Equity Incentive Plan: RSUs outstanding 22,925,982 3,123,995 Shares available for future grants 60,497,288 54,050,260 2021 Employee Stock Purchase Plan: Shares available for future issuance 14,144,817 10,200,000 Total shares of common stock reserved for future issuance 122,382,267 105,454,429 Employee Compensation Plans The Company currently has two equity incentive plans, the 2015 Equity Incentive Plan (the “2015 Plan”) and the 2021 Equity Incentive Plan (the “2021 Plan”). The 2015 Plan was terminated in connection with the adoption of the 2021 Plan in December 2021 but continues to govern the terms of outstanding stock options and RSUs that were granted prior to the termination of the 2015 Plan. The Company no longer grants equity awards pursuant to the 2015 Plan. 2021 Equity Incentive Plan —In December 2021, the Board of Directors adopted and stockholders approved the 2021 Equity Incentive Plan, which became effective in December 2021 in connection with the Company’s initial public offering (“IPO”). A total of 50,600,000 shares of the Company’s Class A common stock initially were reserved for issuance under the 2021 Plan. In addition, the number of shares of the Company’s Class A common stock are increased by (i) any annual automatic evergreen increases in the number of shares of Class A common stock reserved for issuance under the 2021 Plan on the first day of each fiscal year, as determined in accordance with the formula set forth in the 2021 Plan and (ii) a number of shares of Class A common stock equal to the number of shares of Class B common stock subject to equity awards granted under the 2015 Plan that expire, terminate without having been exercised or issued in full, are tendered to or withheld for payment of an exercise price or for tax withholding obligations with respect to a 2015 Plan award, or are forfeited to or repurchased by the Company due to failure to vest, such number of shares under this clause (ii) not to exceed 57,631,084. As of October 29, 2022 and January 29, 2022, the total number of shares of the Company’s Class A common stock reserved for future grants was 60,497,288 and 54,050,260, respectively. The total number of shares of the Company’s Class A common stock reserved for future grants as of October 29, 2022 includes 25,273,808 shares added on the first day of fiscal year 2023 pursuant to the annual automatic evergreen increase provision of the 2021 Plan. Options —A summary of the stock options activity under the 2015 Plan during the nine months ended October 29, 2022 is presented below (the number of options represents shares of Class B common stock exercisable in respect thereof): Number of Shares Weighted-Average Weighted-Average Aggregate Intrinsic Value (1) (In Thousands) Balance as of January 29, 2022 8,628,071 $ 3.77 6.9 $ 111,170 Exercised (1,576,293) $ 0.33 Forfeited, canceled, or expired (6,013) $ 1.16 Balance as of October 29, 2022 7,045,765 $ 4.54 6.6 $ 55,250 Exercisable as of October 29, 2022 5,318,237 $ 3.72 6.2 $ 46,134 __________ (1) Aggregate intrinsic value for stock options represents the difference between the exercise price and the per share fair value of the Company’s Class A common stock for each period end presented, multiplied by the number of stock options outstanding or exercisable as of each period end presented. There were no stock options granted during the nine months ended October 29, 2022 and October 30, 2021. The intrinsic value of stock options exercised was $22.9 million and $46.9 million during the nine months ended October 29, 2022 and October 30, 2021, respectively. As of October 29, 2022, unrecognized stock-based compensation expense related to outstanding unvested stock options for employees that are expected to vest was approximately $6.4 million. The remaining unrecognized stock-based compensation expense is expected to be recognized over a weighted-average period of approximately one year. Early Exercise of Stock Options —Certain stock options granted under the 2015 Plan provide option holders the right to elect to exercise unvested stock options in exchange for restricted common stock. Such unvested restricted shares are subject to a repurchase right held by the Company at the original issuance price, as adjusted to reflect stock splits or similar changes to the Company’s capital structure, in the event the option holder’s service to the Company is terminated either voluntarily or involuntarily. The right lapses as the awards vest. These repurchase terms are considered to be a forfeiture provision. The cash received from option holders for exercises of unvested stock options is treated as a refundable deposit shown as a liability in the Company’s condensed consolidated balance sheets and reclassified to additional paid-in capital as the Company’s repurchase right lapses. As of October 29, 2022 and January 29, 2022, there were 28,502 and 138,710 unvested early exercised shares outstanding, respectively, which remain subject to repurchase. The liability related to such shares was $0.1 million and $0.4 million as of October 29, 2022 and January 29, 2022, respectively. RSUs —RSUs granted prior to the IPO had both a service condition and a performance condition. Stock-based compensation expense is only recognized for RSUs for which both the service condition and performance condition have been met. The service condition for these awards is generally satisfied over four years. The performance condition was satisfied upon the IPO. Prior to the IPO, the Company did not record expense on RSUs as a liquidity event upon which vesting is contingent was not probable of occurring. Following the closing of the IPO in December 2021, the Company began recording stock-based compensation expense for these RSUs using the accelerated attribution method, based on the grant-date fair value of the RSUs. RSUs granted after the IPO only have a service condition, and the related stock-based compensation expense is recognized on a straight-line basis over the requisite service period. A summary of the RSUs activity under the 2015 Plan and 2021 Plan during the nine months ended October 29, 2022 is presented below: Number of Shares Weighted-Average Balance as of January 29, 2022 32,576,098 $ 10.83 Granted 23,429,122 $ 13.40 Vested (10,711,083) $ 10.15 Forfeited (4,599,740) $ 11.25 Balance as of October 29, 2022 40,694,397 $ 12.44 As of October 29, 2022, unrecognized stock-based compensation expense related to outstanding unvested RSUs for employees that are expected to vest was approximately $379.0 million. The remaining unrecognized stock-based compensation expense is expected to be recognized over a weighted-average period of approximately 1.8 years. 2021 Employee Stock Purchase Plan —In December 2021, the Board of Directors adopted and stockholders approved the 2021 Employee Stock Purchase Plan (the “2021 ESPP”), which became effective in December 2021 in connection with the IPO. The 2021 ESPP authorizes the issuance of shares of Class A common stock pursuant to purchase rights granted to eligible employees. A total of 10,200,000 shares of the Company’s Class A common stock initially were reserved for future sale under the 2021 ESPP. In addition, the number of shares of the Company’s Class A common stock are increased by any annual automatic evergreen increases in the number of shares of Class A common stock reserved for future sale under the 2021 ESPP on the first day of each fiscal year, as determined in accordance with the formula set forth in the 2021 ESPP. As of October 29, 2022 and January 29, 2022, the total number of shares of the Company’s Class A common stock reserved for future issuance was 14,144,817 and 10,200,000, respectively. As of October 29, 2022, the total number of shares of the Company’s Class A common stock reserved for future issuance includes the annual automatic evergreen increase of 5,054,762 shares. The price at which Class A common stock is purchased under the 2021 ESPP is equal to 85% of the lower of the fair market value of a share of the Company’s Class A common stock on the enrollment date or on the exercise date. The enrollment date means the first trading day of each offering period, and the exercise date means the last trading day of each purchase period. Offering periods are generally 12 months long, commencing on the first trading day on or after June 11 and December 11 of each year and terminating on the last trading day on or before June 10 and December 10. The first offering period began on the first trading day on or after the Company’s registration date, which was December 15, 2021, and is scheduled to end on the last trading day on or before December 10, 2022, and the second offering period began on June 13, 2022. Purchase periods are generally six months long, commencing on the first trading day after one exercise date and ending with the next exercise date. The first purchase period of the first offering period began on the first trading day on or after the registration date, which was December 15, 2021, and ended on June 10, 2022, and the second purchase period began on June 13, 2022 and is scheduled to end on the last trading day on or before December 10, 2022, which is December 9, 2022. For the nine months ended October 29, 2022, 1,109,945 shares of common stock were purchased under the 2021 ESPP, resulting in net cash proceeds of $10.3 million. As of October 29, 2022, unrecognized stock-based compensation expense related to the 2021 ESPP for employees that are expected to vest was approximately $2.1 million. The remaining unrecognized stock-based compensation expense is expected to be recognized over a weighted-average period of approximately 0.3 years. Employee Stock Purchase Plan Valuation —The Company estimates the fair value of shares to be issued under the 2021 ESPP using the Black-Scholes option-pricing model. The Black-Scholes option-pricing model requires estimates of highly subjective assumptions, which greatly affect fair value. The weighted-average assumptions used to estimate the fair value of shares to be issued under the 2021 ESPP which were granted during the nine months ended October 29, 2022 were as follows: June 2022 Offering Period Purchase Period 1 Purchase Period 2 Expected volatility 97.7 % 81.0 % Expected term (years) 0.5 1.0 Risk-free interest rate 2.3 % 2.9 % Expected dividend yield — % — % Expected volatility —The expected volatility was based on the historical volatility of the Company and similar companies whose stock or option prices are publicly available, after considering the industry, stage of life cycle, size, market capitalization, and financial leverage of the other companies. Expected term (years) —For all offering periods subsequent to the first offering period, the expected term is approximately 0.5 years for the first purchase period and approximately 1.0 year for the second purchase period. Risk-free interest rate —The risk-free interest rate assumption is based on observed U.S. Treasury yield curve interest rates in effect at the time of grant appropriate for the expected term of the stock-based award. Expected dividend yield —Because the Company has never paid and has no intention to pay cash dividends on its common stock, the expected dividend yield is zero. Stock-Based Compensation Expense —Stock-based compensation expense, by grant type, was as follows (in thousands): Three Months Ended Nine Months Ended October 29, 2022 October 30, 2021 October 29, 2022 October 30, 2021 Stock options $ 1,081 $ 1,221 $ 3,305 $ 3,988 RSUs 41,537 — 120,888 — ESPP 2,920 — 9,297 — Total stock-based compensation expense $ 45,538 $ 1,221 $ 133,490 $ 3,988 Stock-based compensation expense included in the following line items of the Company’s condensed consolidated statements of operations and comprehensive loss was as follows (in thousands): Three Months Ended Nine Months Ended October 29, 2022 October 30, 2021 October 29, 2022 October 30, 2021 Cost of revenue $ 2,589 $ 9 $ 6,834 $ 10 Research and development 17,928 219 45,398 550 Sales and marketing 12,292 84 41,159 381 General and administrative 12,729 909 40,099 3,047 Total stock-based compensation expense $ 45,538 $ 1,221 $ 133,490 $ 3,988

Income Taxes

Income Taxes	9 Months Ended
	Oct. 29, 2022
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes The Company had an effective tax rate of (1.2)% and (0.1)% for the three months ended October 29, 2022 and October 30, 2021, respectively, and (0.8)% and (0.4)% for the nine months ended October 29, 2022 and October 30, 2021, respectively. The Company’s provision for income taxes was $0.7 million and immaterial for the three months ended October 29, 2022 and October 30, 2021, respectively, and $1.5 million and $0.4 million for the nine months ended October 29, 2022 and October 30, 2021, respectively. The Company has incurred U.S. operating losses and has minimal profits in foreign jurisdictions. The Company computes its tax provision for interim periods by applying the estimated annual effective tax rate to year-to-date pre-tax income from recurring operations and adjusting for discrete tax items arising in that quarter. As of October 29, 2022 and January 29, 2022, based on all available objective evidence, including the existence of cumulative losses, the Company determined that it was not more likely than not that the net deferred tax assets were fully realizable. Accordingly, the Company established a full valuation allowance against its deferred tax assets. The Company intends to maintain a full valuation allowance on net deferred tax assets until sufficient positive evidence exists to support reversal of the valuation allowance. The unrecognized tax benefits for the nine months ended October 29, 2022 and October 30, 2021, if recognized, would not affect the effective income tax rate due to the valuation allowance that currently offsets the deferred tax assets. The Company recognizes interest and penalties related to income tax matters as a component of income tax expense. The Company had no interest and penalties accrued as of October 29, 2022 and January 29, 2022. The Company does not expect the unrecognized tax benefits to change significantly over the next 12 months. The Company files income tax returns in the U.S. federal jurisdiction and various states and foreign jurisdictions. All periods since inception are subject to examination by U.S. federal, state, and foreign authorities, where applicable. There are currently no pending income tax examinations.

Net Loss Per Share, Basic and D

Net Loss Per Share, Basic and Diluted	9 Months Ended
	Oct. 29, 2022
Earnings Per Share [Abstract]
Net Loss Per Share, Basic and Diluted	Net Loss Per Share, Basic and Diluted For purposes of calculating net loss per share, the Company continues to use the two-class method. As Class A, Class B, and Class C common stock have identical liquidation and dividend rights, the undistributed earnings are allocated on a proportionate basis to each class of common stock. As a result, the basic and diluted net loss per share are the same for all classes of Samsara’s common stock on both an individual and combined basis and therefore are presented together. The following table presents the calculation of basic and diluted net loss per share (in thousands, except share and per share data): Three Months Ended Nine Months Ended October 29, 2022 October 30, 2021 October 29, 2022 October 30, 2021 Numerator: Net loss $ (58,555) $ (32,446) $ (193,824) $ (102,257) Net loss attributable to common stockholders (58,555) (32,446) (193,824) (102,257) Denominator: Weighted-average shares used in computing net loss per share attributable to common stockholders, basic and diluted 516,551,258 246,811,235 511,867,718 246,174,612 Net loss per share attributable to common stockholders, basic and diluted $ (0.11) $ (0.13) $ (0.38) $ (0.42) The following potentially dilutive securities were excluded from the computation of diluted net loss per share calculations for the periods presented because the impact of including them would have been antidilutive: Three Months Ended Nine Months Ended October 29, 2022 October 30, 2021 October 29, 2022 October 30, 2021 Convertible preferred stock — 205,638,256 — 205,638,256 Outstanding stock options 7,045,765 9,259,852 7,045,765 9,259,852 RSUs 40,694,397 48,564,016 40,694,397 48,564,016 ESPP 46,822 — 11,751 — Total antidilutive securities 47,786,984 263,462,124 47,751,913 263,462,124

Segment Information

Segment Information	9 Months Ended
	Oct. 29, 2022
Segment Reporting [Abstract]
Segment Information	Segment InformationThe Company has a single operating and reportable segment. The Company’s chief operating decision maker is its Chief Executive Officer, who reviews financial information presented on a consolidated basis for purposes of making operating decisions, assessing financial performance, and allocating resources. Revenue by Geographic Area The following table presents the Company’s revenue disaggregated by geography, based on the location of the Company’s customers (in thousands): Three Months Ended Nine Months Ended October 29, 2022 October 30, 2021 October 29, 2022 October 30, 2021 United States $ 151,747 $ 101,969 $ 415,871 $ 271,801 Other (1) 18,053 11,850 50,097 30,792 Total revenue $ 169,800 $ 113,819 $ 465,968 $ 302,593 __________ (1) No individual country, other than disclosed above, exceeded 10% of the Company’s total revenue for any period presented. Long-Lived Assets, Net, by Geographic Area The following table presents the Company’s long-lived assets, net, disaggregated by geography, which consist of property and equipment, net, and operating lease ROU assets (in thousands): As of October 29, 2022 January 29, 2022 United States $ 166,708 $ 160,310 Other (1) 9,161 10,889 Total long-lived assets, net $ 175,869 $ 171,199 __________ (1) No individual country, other than disclosed above, exceeded 10% of the Company’s total long-lived assets, net, for any period presented.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	9 Months Ended
	Oct. 29, 2022
Accounting Policies [Abstract]
Basis of Presentation and Fiscal Year	Basis of Presentation and Fiscal Year —The accompanying unaudited condensed consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”) and applicable rules and regulations of the U.S. Securities and Exchange Commission (“SEC”) regarding interim financial reporting. Accordingly, they do not include all disclosures normally required in annual consolidated financial statements prepared in accordance with GAAP. Therefore, these unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes included in the Company’s Annual Report on Form 10-K for the fiscal year ended January 29, 2022, which was filed with the SEC on March 30, 2022. In management’s opinion, these unaudited condensed consolidated financial statements have been prepared on the same basis as the annual financial statements and reflect all adjustments, which include only normal recurring adjustments necessary for the fair statement of the Company’s financial position as of October 29, 2022 and the results of operations for the three and nine months ended October 29, 2022 and October 30, 2021, and cash flows for the nine months ended October 29, 2022 and October 30, 2021. The condensed consolidated balance sheet as of January 29, 2022 was derived from the audited financial statements but does not include all disclosures required by GAAP. The results of operations for the three and nine months ended October 29, 2022 are not necessarily indicative of the results to be expected for the full year or any other future interim or annual period. The Company’s fiscal year is a 52- or 53-week period ending on the Saturday closest to February 1. Fiscal year 2023 consists of 52 weeks and fiscal year 2022 consisted of 52 weeks. Every sixth fiscal year is a 53-week year. Fiscal year 2024 is the Company’s next 53-week fiscal year, with the fourth quarter consisting of 14 weeks.
Principles of Consolidation	Principles of Consolidation —The condensed consolidated financial statements include the accounts of Samsara and its wholly owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation.
Use of Estimates	Use of Estimates —The preparation of condensed consolidated financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and accompanying notes. Such management estimates include, but are not limited to, the fair value of stock-based awards, internal-use software development costs, sales return reserve, accrued liabilities and contingencies, depreciation and amortization periods, lease modification, impairment, and related charges, and accounting for income taxes. Actual results could materially differ from the estimates and assumptions made.
Investments	Investments —The Company’s investments in marketable debt securities have been classified and accounted for as available-for-sale and are recorded at estimated fair value. The Company determines the appropriate classification of investments at the time of purchase and reevaluates such determination at each balance sheet date and classifies its marketable debt securities as either short-term or long-term based on their remaining contractual maturities. Short-term investments are investments with original or remaining maturities of one year or less at each balance sheet date. Purchase premiums and discounts are amortized or accreted using the effective interest method over the life of the related security and such amortization and accretion are included in “Interest income and other income (expense), net” on the condensed consolidated statements of operations and comprehensive loss. For available-for-sale securities in an unrealized loss position, the Company first assesses whether it intends to sell or it is more likely than not that the Company will be required to sell the security before the recovery of its entire amortized cost basis. If either of these criteria is met, the security’s amortized cost basis is written down to fair value through “Interest income and other income (expense), net” on the condensed consolidated statements of operations and comprehensive loss. If neither of these criteria is met, the Company further assesses whether the decline in fair value below amortized cost is due to credit or non-credit related factors. In making this assessment, the Company considers the extent to which fair value is less than amortized cost, any changes to the rating of the security by a rating agency, and any adverse conditions specifically related to the security, among other factors. Credit-related unrealized losses are recognized as an allowance on the condensed consolidated balance sheets with a corresponding charge in “Interest income and other income (expense), net” on the condensed consolidated statements of operations and comprehensive loss. Non-credit related unrealized losses and unrealized gains on available-for-sale securities are included in accumulated other comprehensive income (loss). Realized gains and losses are determined based on the specific identification method and are reported in “Interest income and other income (expense), net” on the condensed consolidated statements of operations and comprehensive loss. See Note 4, “Fair Value Measurements,” for information regarding the fair value of the Company’s investments in marketable debt securities.
Recently Adopted Accounting Pronouncements and Recent Accounting Pronouncements Not Yet Adopted	Recently Adopted Accounting Pronouncements —There were no new accounting pronouncements adopted during the nine months ended October 29, 2022. Recent Accounting Pronouncements Not Yet Adopted —In June 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2016-13, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments . This standard changes the methodology for measuring credit losses on financial instruments and the timing of when such losses are recorded. In April 2019, the FASB issued ASU No. 2019-04, Codification Improvements to Topic 326, Financial Instruments—Credit Losses, Topic 815 , Derivatives and Hedging, and Topic 825, Financial Instruments . The amendments in this update represent changes to clarify, correct errors in, or improve the codification. In May 2019, the FASB issued ASU No. 2019-05, Financial Instruments—Credit Losses (Topic 326) . The amendments in this update provide entities that have certain instruments within the scope of Subtopic 326-20, Financial Instruments—Credit Losses—Measured at Amortized Cost , with an option to irrevocably elect the fair value option in Subtopic 825-10, Financial Instruments—Overall , applied on an instrument-by-instrument basis for eligible instruments, upon adoption of Topic 326. This guidance is effective for the Company for its fiscal year beginning January 29, 2023. The standard requires a modified retrospective method of adoption. This new standard is not expected to have a material impact on the Company’s consolidated financial statements. The Company has reviewed all other recently issued accounting pronouncements and concluded they were either not applicable or not expected to have a material impact on the Company’s consolidated financial statements.
Fair Value Measurements	The Company reports all financial assets and liabilities and nonfinancial assets and liabilities that are recognized or disclosed at fair value in the condensed consolidated financial statements on a recurring basis. The authoritative guidance establishes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to measurements involving significant unobservable inputs (Level 3 measurements). The three levels of the fair value hierarchy are as follows: Level 1 —Observable inputs that reflect quoted prices (unadjusted) in active markets for identical assets or liabilities. Level 2 —Observable inputs other than quoted prices in active markets for identical assets or liabilities, quoted prices for identical or similar assets or liabilities in inactive markets, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. Level 3 —Inputs that are generally unobservable and typically reflect management’s estimates of assumptions that market participants would use in pricing the asset or liability. The level in the fair value hierarchy within which a fair value measurement in its entirety falls is based on the lowest-level input that is significant to the fair value measurement in its entirety.
Revenue Recognition	Subscription revenue is generated from subscriptions to access the Company’s Connected Operations Cloud. Subscription agreements contain multiple service elements for one or more of the Company’s cloud-based Applications via mobile app(s) or a website that enable data collection and provide access to the cellular network, generally one or more wireless gateways, cameras, sensors and other devices (collectively, “connected devices” or “IoT devices”), support services delivered over the term of the arrangement and warranty coverage. The Company’s Connected Operations Cloud and the related connected device access points are highly interdependent and interrelated, and represent a combined performance obligation, which is recognized over the related subscription period.Other revenue is generally recognized at a point in time and is earned through the sale of replacement gateways, sensors and cameras, as well as related shipping and handling fees, credit card processing fees, and professional services.
Net Loss Per Share	For purposes of calculating net loss per share, the Company continues to use the two-class method. As Class A, Class B, and Class C common stock have identical liquidation and dividend rights, the undistributed earnings are allocated on a proportionate basis to each class of common stock. As a result, the basic and diluted net loss per share are the same for all classes of Samsara’s common stock on both an individual and combined basis and therefore are presented together.

Cash, Cash Equivalents, Restr_2

Cash, Cash Equivalents, Restricted Cash, and Investments (Tables)	9 Months Ended
	Oct. 29, 2022
Cash and Cash Equivalents [Abstract]
Schedule of Cash and Cash Equivalents	Total cash, cash equivalents, and restricted cash consist of the following (in thousands): As of October 29, 2022 January 29, 2022 Cash and cash equivalents $ 447,040 $ 921,218 Restricted cash 23,096 23,092 Total cash, cash equivalents, and restricted cash $ 470,136 $ 944,310
Schedule of Restricted Cash	Total cash, cash equivalents, and restricted cash consist of the following (in thousands): As of October 29, 2022 January 29, 2022 Cash and cash equivalents $ 447,040 $ 921,218 Restricted cash 23,096 23,092 Total cash, cash equivalents, and restricted cash $ 470,136 $ 944,310
Summary of Cash Equivalents and Available for Sale Marketable Securities	The following is a summary of the Company’s cash equivalents and available-for-sale marketable debt securities recorded within short-term and long-term investments on the condensed consolidated balance sheets (in thousands): As of October 29, 2022 Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Estimated Fair Value Cash equivalents: Money market funds $ 37,282 $ — $ — $ 37,282 Commercial paper 211,820 — (18) 211,802 U.S. government and agency securities 41,893 1 (14) 41,880 Corporate notes and bonds 4,998 — (4) 4,994 Total cash equivalents $ 295,993 $ 1 $ (36) $ 295,958 Investments: Commercial paper 134,467 — (14) 134,453 Corporate notes and bonds 112,757 5 (605) 112,157 U.S. government and agency securities $ 109,548 $ 6 $ (661) $ 108,893 Total investments $ 356,772 $ 11 $ (1,280) $ 355,503
Schedule of Fair Values of Available for Sale Marketable Securities	The estimated fair values of available-for-sale marketable debt securities, by remaining contractual maturity, are as follows (in thousands): As of October 29, 2022 Due within one year $ 291,815 Due in one year to two years 63,688 Total $ 355,503

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	9 Months Ended
	Oct. 29, 2022
Fair Value Disclosures [Abstract]
Fair Value, Assets Measured on Recurring Basis	The following tables present the fair value hierarchy for the Company’s assets measured at fair value on a recurring basis as of the periods presented (in thousands): As of October 29, 2022 Level 1 Level 2 Level 3 Total Cash equivalents and restricted cash: Cash equivalents Money market funds $ 160,378 $ — $ — $ 160,378 Commercial paper — 211,802 — 211,802 U.S. government and agency securities — 41,880 — 41,880 Corporate notes and bonds — 4,994 — 4,994 Restricted cash—letters of credit 23,096 — — 23,096 Total cash equivalents and restricted cash $ 183,474 $ 258,676 $ — $ 442,150 Marketable debt securities: Commercial paper $ — $ 134,453 $ — $ 134,453 Corporate notes and bonds — 112,157 — 112,157 U.S. government and agency securities — 108,893 — 108,893 Total marketable debt securities $ — $ 355,503 $ — $ 355,503 As of January 29, 2022 Level 1 Level 2 Level 3 Total Cash equivalents—money market funds $ 866,364 $ — $ — $ 866,364 Restricted cash—letters of credit 23,092 — — 23,092 Total cash equivalents and restricted cash $ 889,456 $ — $ — $ 889,456

Costs to Obtain and Fulfill a_2

Costs to Obtain and Fulfill a Contract (Tables)	9 Months Ended
	Oct. 29, 2022
Revenue from Contract with Customer [Abstract]
Schedule of Capitalized Contract Costs	The following table provides the amounts capitalized and amortized for the Company’s commission costs for the periods presented (in thousands): Three Months Ended Nine Months Ended October 29, 2022 October 30, 2021 October 29, 2022 October 30, 2021 Capitalized commission costs $ 16,599 $ 17,401 $ 47,442 $ 48,979 Amortization expense 12,477 11,982 36,987 34,210 The following table provides the amounts capitalized and amortized for the Company’s connected device costs for the periods presented (in thousands): Three Months Ended Nine Months Ended October 29, 2022 October 30, 2021 October 29, 2022 October 30, 2021 Capitalized connected device costs $ 39,244 $ 31,051 $ 105,014 $ 89,979 Amortization expense 17,048 10,672 46,020 27,545

Property and Equipment, Net (Ta

Property and Equipment, Net (Tables)	9 Months Ended
	Oct. 29, 2022
Property, Plant and Equipment [Abstract]
Property and Equipment, Net	Property and equipment, net, comprises the following (in thousands): As of October 29, 2022 January 29, 2022 Gross property and equipment Computers and equipment $ 1,206 $ 834 Leasehold improvements 45,982 24,752 Furniture and fixtures 19,765 16,854 Internal-use software development costs (1) 20,706 16,152 Total gross property and equipment 87,659 58,592 Accumulated depreciation and amortization (2) (30,301) (21,820) Property and equipment, net $ 57,358 $ 36,772 __________ (1) The Company’s internal-use software development costs included $0.5 million and $1.1 million of stock-based compensation costs for the three and nine months ended October 29, 2022, respectively, and an immaterial amount of stock-based compensation costs for the three and nine months ended October 30, 2021. The following table provides the amounts capitalized and amortized for the Company’s internal-use software development costs for the periods presented (in thousands): Three Months Ended Nine Months Ended October 29, 2022 October 30, 2021 October 29, 2022 October 30, 2021 Capitalized internal-use software development costs $ 2,003 $ 1,310 $ 4,554 $ 3,226 Amortization expense $ 934 $ 856 $ 2,911 $ 2,398 Internal-use software development costs, net, as of the periods presented was as follows (in thousands): As of October 29, 2022 January 29, 2022 Internal-use software development costs, net $ 8,168 $ 6,747 (2) The following table presents the depreciation and amortization of property and equipment, excluding the accelerated depreciation expense of $29.7 million recorded in connection with the lease modification during the three and nine months ended October 30, 2021, which is included in “Lease modification, impairment, and related charges” on the Company’s condensed consolidated statements of operations and comprehensive loss (in thousands): Three Months Ended Nine Months Ended October 29, 2022 October 30, 2021 October 29, 2022 October 30, 2021 Depreciation and amortization expense $ 3,345 $ 512 $ 8,350 $ 5,819

Leases (Tables)

Leases (Tables)	9 Months Ended
	Oct. 29, 2022
Leases [Abstract]
Lease Costs	The components of operating lease expense were as follows (in thousands): Three Months Ended Nine Months Ended October 29, 2022 October 30, 2021 October 29, 2022 October 30, 2021 Operating lease cost $ 6,333 $ 6,146 $ 19,096 $ 17,686 Short-term lease cost 172 45 486 157 Sublease income (195) (75) (581) (75) Total lease cost $ 6,310 $ 6,116 $ 19,001 $ 17,768 Supplemental information related to operating leases was as follows (in thousands, except for weighted-average data): Three Months Ended Nine Months Ended October 29, 2022 October 30, 2021 October 29, 2022 October 30, 2021 Cash paid for amounts in the measurement of operating lease liabilities—operating cash flows $ 6,725 $ 8,418 $ 20,017 $ 18,856 Operating lease ROU assets obtained in exchange for new operating lease liabilities $ — $ 19,135 $ — $ 19,135 As of October 29, 2022 January 29, 2022 Weighted-average remaining lease term—operating leases (in years) 6.6 7.1 Weighted-average discount rate—operating leases 4.49 % 4.38 %
Future Minimum Lease Payments	Future minimum lease payments included in the measurement of operating lease liabilities as of October 29, 2022 were as follows (in thousands): Fiscal Years Ending Amount Remainder of 2023 $ 6,772 2024 26,853 2025 26,850 2026 19,946 2027 14,236 2028 and thereafter 56,239 Total future minimum lease payments (1) 150,896 Less: imputed interest (23,013) Total operating lease liabilities $ 127,883 __________ (1) The contractual commitment amounts under operating leases in the table above are primarily related to facility leases for the Company’s corporate office facilities in San Francisco, California, which was completed in the second quarter of fiscal year 2023, as well as other offices for the Company’s local operations. The table above does not reflect obligations under contracts that the Company can cancel without a significant penalty, the Company’s option to exercise early termination rights, or the payment of related early termination fees.

Deferred Revenue and Remainin_2

Deferred Revenue and Remaining Performance Obligations (Tables)	9 Months Ended
	Oct. 29, 2022
Revenue from Contract with Customer [Abstract]
Schedule of Revenue	Revenue consists of the following (in thousands): Three Months Ended Nine Months Ended October 29, 2022 October 30, 2021 October 29, 2022 October 30, 2021 Subscription revenue $ 166,555 $ 108,981 $ 457,083 $ 294,743 Other revenue 3,245 4,838 8,885 7,850 Total revenue $ 169,800 $ 113,819 $ 465,968 $ 302,593
Schedule of Deferred Revenue	The following table provides the deferred revenue balances and revenue recognized from beginning deferred revenue balances for the periods presented (in thousands): Three Months Ended Nine Months Ended October 29, 2022 October 30, 2021 October 29, 2022 October 30, 2021 Deferred revenue, beginning of period $ 354,570 $ 274,332 $ 313,686 $ 249,572 Deferred revenue, end of period 374,243 286,509 374,243 286,509 Revenue recognized in the period from beginning deferred revenue balance 156,716 116,586 188,197 127,068

Equity (Tables)

Equity (Tables)	9 Months Ended
	Oct. 29, 2022
Equity [Abstract]
Schedule of Reserved Shares of Common Stock for Future Issuance	The Company had reserved shares of common stock for future issuance as of October 29, 2022 and January 29, 2022, as follows: As of October 29, 2022 January 29, 2022 2015 Equity Incentive Plan: Options outstanding 7,045,765 8,628,071 RSUs outstanding 17,768,415 29,452,103 2021 Equity Incentive Plan: RSUs outstanding 22,925,982 3,123,995 Shares available for future grants 60,497,288 54,050,260 2021 Employee Stock Purchase Plan: Shares available for future issuance 14,144,817 10,200,000 Total shares of common stock reserved for future issuance 122,382,267 105,454,429
Summary of Stock Option Activity	A summary of the stock options activity under the 2015 Plan during the nine months ended October 29, 2022 is presented below (the number of options represents shares of Class B common stock exercisable in respect thereof): Number of Shares Weighted-Average Weighted-Average Aggregate Intrinsic Value (1) (In Thousands) Balance as of January 29, 2022 8,628,071 $ 3.77 6.9 $ 111,170 Exercised (1,576,293) $ 0.33 Forfeited, canceled, or expired (6,013) $ 1.16 Balance as of October 29, 2022 7,045,765 $ 4.54 6.6 $ 55,250 Exercisable as of October 29, 2022 5,318,237 $ 3.72 6.2 $ 46,134 __________ (1) Aggregate intrinsic value for stock options represents the difference between the exercise price and the per share fair value of the Company’s Class A common stock for each period end presented, multiplied by the number of stock options outstanding or exercisable as of each period end presented.
Summary of RSU Activity	A summary of the RSUs activity under the 2015 Plan and 2021 Plan during the nine months ended October 29, 2022 is presented below: Number of Shares Weighted-Average Balance as of January 29, 2022 32,576,098 $ 10.83 Granted 23,429,122 $ 13.40 Vested (10,711,083) $ 10.15 Forfeited (4,599,740) $ 11.25 Balance as of October 29, 2022 40,694,397 $ 12.44
Schedule of Weighted Average Assumptions Used to Estimate Fair Value of ESPP Shares	The weighted-average assumptions used to estimate the fair value of shares to be issued under the 2021 ESPP which were granted during the nine months ended October 29, 2022 were as follows: June 2022 Offering Period Purchase Period 1 Purchase Period 2 Expected volatility 97.7 % 81.0 % Expected term (years) 0.5 1.0 Risk-free interest rate 2.3 % 2.9 % Expected dividend yield — % — %
Summary of Stock-Based Compensation Expense	Stock-based compensation expense, by grant type, was as follows (in thousands): Three Months Ended Nine Months Ended October 29, 2022 October 30, 2021 October 29, 2022 October 30, 2021 Stock options $ 1,081 $ 1,221 $ 3,305 $ 3,988 RSUs 41,537 — 120,888 — ESPP 2,920 — 9,297 — Total stock-based compensation expense $ 45,538 $ 1,221 $ 133,490 $ 3,988 Stock-based compensation expense included in the following line items of the Company’s condensed consolidated statements of operations and comprehensive loss was as follows (in thousands): Three Months Ended Nine Months Ended October 29, 2022 October 30, 2021 October 29, 2022 October 30, 2021 Cost of revenue $ 2,589 $ 9 $ 6,834 $ 10 Research and development 17,928 219 45,398 550 Sales and marketing 12,292 84 41,159 381 General and administrative 12,729 909 40,099 3,047 Total stock-based compensation expense $ 45,538 $ 1,221 $ 133,490 $ 3,988

Net Loss Per Share, Basic and_2

Net Loss Per Share, Basic and Diluted (Tables)	9 Months Ended
	Oct. 29, 2022
Earnings Per Share [Abstract]
Schedule of Basic and Diluted Net Loss Per Share	The following table presents the calculation of basic and diluted net loss per share (in thousands, except share and per share data): Three Months Ended Nine Months Ended October 29, 2022 October 30, 2021 October 29, 2022 October 30, 2021 Numerator: Net loss $ (58,555) $ (32,446) $ (193,824) $ (102,257) Net loss attributable to common stockholders (58,555) (32,446) (193,824) (102,257) Denominator: Weighted-average shares used in computing net loss per share attributable to common stockholders, basic and diluted 516,551,258 246,811,235 511,867,718 246,174,612 Net loss per share attributable to common stockholders, basic and diluted $ (0.11) $ (0.13) $ (0.38) $ (0.42)
Schedule of Potentially Dilutive Securities Excluded from the Computation of Diluted Net Loss per Share	The following potentially dilutive securities were excluded from the computation of diluted net loss per share calculations for the periods presented because the impact of including them would have been antidilutive: Three Months Ended Nine Months Ended October 29, 2022 October 30, 2021 October 29, 2022 October 30, 2021 Convertible preferred stock — 205,638,256 — 205,638,256 Outstanding stock options 7,045,765 9,259,852 7,045,765 9,259,852 RSUs 40,694,397 48,564,016 40,694,397 48,564,016 ESPP 46,822 — 11,751 — Total antidilutive securities 47,786,984 263,462,124 47,751,913 263,462,124

Segment Information (Tables)

Segment Information (Tables)	9 Months Ended
	Oct. 29, 2022
Segment Reporting [Abstract]
Revenue from External Customers by Geographic Areas	The following table presents the Company’s revenue disaggregated by geography, based on the location of the Company’s customers (in thousands): Three Months Ended Nine Months Ended October 29, 2022 October 30, 2021 October 29, 2022 October 30, 2021 United States $ 151,747 $ 101,969 $ 415,871 $ 271,801 Other (1) 18,053 11,850 50,097 30,792 Total revenue $ 169,800 $ 113,819 $ 465,968 $ 302,593 __________ (1) No individual country, other than disclosed above, exceeded 10% of the Company’s total revenue for any period presented.
Long-lived Assets by Geographic Areas	The following table presents the Company’s long-lived assets, net, disaggregated by geography, which consist of property and equipment, net, and operating lease ROU assets (in thousands): As of October 29, 2022 January 29, 2022 United States $ 166,708 $ 160,310 Other (1) 9,161 10,889 Total long-lived assets, net $ 175,869 $ 171,199 __________ (1) No individual country, other than disclosed above, exceeded 10% of the Company’s total long-lived assets, net, for any period presented.

Cash, Cash Equivalents, Restr_3

Cash, Cash Equivalents, Restricted Cash, and Investments - Schedule of Cash, Cash Equivalents, and Restricted Cash (Details) - USD ($) $ in Thousands	Oct. 29, 2022	Jan. 29, 2022	Oct. 30, 2021	Jan. 30, 2021
Cash and Cash Equivalents [Abstract]
Cash and cash equivalents	$ 447,040	$ 921,218
Restricted cash	23,096	23,092
Total cash, cash equivalents, and restricted cash	$ 470,136	$ 944,310	$ 299,260	$ 434,309

Cash, Cash Equivalents, Restr_4

Cash, Cash Equivalents, Restricted Cash, and Investments - Summary of Cash Equivalents and Available for Sale Marketable Securities (Details) $ in Thousands	Oct. 29, 2022 USD ($)
Cash equivalents:
Amortized Cost	$ 295,993
Gross Unrealized Gains	1
Gross Unrealized Losses	(36)
Estimated Fair Value	295,958
Investments:
Amortized Cost	356,772
Gross Unrealized Gains	11
Gross Unrealized Losses	(1,280)
Estimated Fair Value	355,503
Commercial paper
Investments:
Amortized Cost	134,467
Gross Unrealized Gains	0
Gross Unrealized Losses	(14)
Estimated Fair Value	134,453
Corporate notes and bonds
Investments:
Amortized Cost	112,757
Gross Unrealized Gains	5
Gross Unrealized Losses	(605)
Estimated Fair Value	112,157
U.S. government and agency securities
Investments:
Amortized Cost	109,548
Gross Unrealized Gains	6
Gross Unrealized Losses	(661)
Estimated Fair Value	108,893
Money market funds
Cash equivalents:
Amortized Cost	37,282
Gross Unrealized Gains	0
Gross Unrealized Losses	0
Estimated Fair Value	37,282
Commercial paper
Cash equivalents:
Amortized Cost	211,820
Gross Unrealized Gains	0
Gross Unrealized Losses	(18)
Estimated Fair Value	211,802
U.S. government and agency securities
Cash equivalents:
Amortized Cost	41,893
Gross Unrealized Gains	1
Gross Unrealized Losses	(14)
Estimated Fair Value	41,880
Corporate notes and bonds
Cash equivalents:
Amortized Cost	4,998
Gross Unrealized Gains	0
Gross Unrealized Losses	(4)
Estimated Fair Value	$ 4,994

Cash, Cash Equivalents, Restr_5

Cash, Cash Equivalents, Restricted Cash, and Investments - Narrative (Details)	3 Months Ended	9 Months Ended
	Oct. 29, 2022 USD ($)	Oct. 29, 2022 USD ($)
Cash and Cash Equivalents [Abstract]
Interest receivable	$ 1,000,000	$ 1,000,000
Contractual maturities of available-for-sale debt securities, maximum	24 months	24 months
Debt securities, available-for-sale, realized gain (loss)	$ 0	$ 0
Debt securities, available-for-sale, unrealized gain (loss)	$ 0	$ 0

Cash, Cash Equivalents, Restr_6

Cash, Cash Equivalents, Restricted Cash, and Investments - Schedule of Fair Values of Available for Sale Marketable Securities (Details) $ in Thousands	Oct. 29, 2022 USD ($)
Cash and Cash Equivalents [Abstract]
Due within one year	$ 291,815
Due in one year to two years	63,688
Total	$ 355,503

Fair Value Measurements (Detail

Fair Value Measurements (Details) - USD ($) $ in Thousands	Oct. 29, 2022	Jan. 29, 2022
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Marketable securities	$ 355,503
Commercial paper
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Marketable securities	134,453
Corporate notes and bonds
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Marketable securities	112,157
U.S. government and agency securities
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Marketable securities	108,893
Fair Value, Recurring
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Cash equivalents		$ 866,364
Restricted cash—letters of credit	23,096	23,092
Total cash equivalents and restricted cash	442,150	889,456
Marketable securities	355,503
Fair Value, Recurring | Commercial paper
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Marketable securities	134,453
Fair Value, Recurring | Corporate notes and bonds
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Marketable securities	112,157
Fair Value, Recurring | U.S. government and agency securities
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Marketable securities	108,893
Fair Value, Recurring | Money market funds
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Cash equivalents	160,378
Fair Value, Recurring | Commercial paper
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Cash equivalents	211,802
Fair Value, Recurring | U.S. government and agency securities
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Cash equivalents	41,880
Fair Value, Recurring | Corporate notes and bonds
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Cash equivalents	4,994
Fair Value, Recurring | Level 1
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Cash equivalents		866,364
Restricted cash—letters of credit	23,096	23,092
Total cash equivalents and restricted cash	183,474	889,456
Marketable securities	0
Fair Value, Recurring | Level 1 | Commercial paper
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Marketable securities	0
Fair Value, Recurring | Level 1 | Corporate notes and bonds
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Marketable securities	0
Fair Value, Recurring | Level 1 | U.S. government and agency securities
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Marketable securities	0
Fair Value, Recurring | Level 1 | Money market funds
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Cash equivalents	160,378
Fair Value, Recurring | Level 1 | Commercial paper
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Cash equivalents	0
Fair Value, Recurring | Level 1 | U.S. government and agency securities
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Cash equivalents	0
Fair Value, Recurring | Level 1 | Corporate notes and bonds
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Cash equivalents	0
Fair Value, Recurring | Level 2
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Cash equivalents		0
Restricted cash—letters of credit	0	0
Total cash equivalents and restricted cash	258,676	0
Marketable securities	355,503
Fair Value, Recurring | Level 2 | Commercial paper
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Marketable securities	134,453
Fair Value, Recurring | Level 2 | Corporate notes and bonds
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Marketable securities	112,157
Fair Value, Recurring | Level 2 | U.S. government and agency securities
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Marketable securities	108,893
Fair Value, Recurring | Level 2 | Money market funds
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Cash equivalents	0
Fair Value, Recurring | Level 2 | Commercial paper
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Cash equivalents	211,802
Fair Value, Recurring | Level 2 | U.S. government and agency securities
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Cash equivalents	41,880
Fair Value, Recurring | Level 2 | Corporate notes and bonds
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Cash equivalents	4,994
Fair Value, Recurring | Level 3
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Cash equivalents		0
Restricted cash—letters of credit	0	0
Total cash equivalents and restricted cash	0	$ 0
Marketable securities	0
Fair Value, Recurring | Level 3 | Commercial paper
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Marketable securities	0
Fair Value, Recurring | Level 3 | Corporate notes and bonds
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Marketable securities	0
Fair Value, Recurring | Level 3 | U.S. government and agency securities
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Marketable securities	0
Fair Value, Recurring | Level 3 | Money market funds
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Cash equivalents	0
Fair Value, Recurring | Level 3 | Commercial paper
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Cash equivalents	0
Fair Value, Recurring | Level 3 | U.S. government and agency securities
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Cash equivalents	0
Fair Value, Recurring | Level 3 | Corporate notes and bonds
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Cash equivalents	$ 0

Costs to Obtain and Fulfill a_3

Costs to Obtain and Fulfill a Contract - Narrative (Details) - USD ($) $ in Thousands	Oct. 29, 2022	Jan. 29, 2022
Capitalized Contract Cost [Line Items]
Deferred commissions	$ 128,212	$ 117,757
Connected Device Costs
Capitalized Contract Cost [Line Items]
Capitalized contract cost	$ 252,800	$ 193,800

Costs to Obtain and Fulfill a_4

Costs to Obtain and Fulfill a Contract - Schedule of Capitalized Commission Costs (Details) - Commission Costs - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 29, 2022	Oct. 30, 2021	Oct. 29, 2022	Oct. 30, 2021
Summary Of Significant Accounting Policies [Line Items]
Capitalized commission costs	$ 16,599	$ 17,401	$ 47,442	$ 48,979
Amortization expense	$ 12,477	$ 11,982	$ 36,987	$ 34,210

Costs to Obtain and Fulfill a_5

Costs to Obtain and Fulfill a Contract - Schedule of Capitalized Connected Device Costs (Details) - Connected Device Costs - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 29, 2022	Oct. 30, 2021	Oct. 29, 2022	Oct. 30, 2021
Capitalized Contract Cost [Line Items]
Capitalized connected device costs	$ 39,244	$ 31,051	$ 105,014	$ 89,979
Amortization expense	$ 17,048	$ 10,672	$ 46,020	$ 27,545

Property and Equipment, Net - S

Property and Equipment, Net - Summary of Property and Equipment (Details) - USD ($)	3 Months Ended		9 Months Ended
	Oct. 29, 2022	Oct. 30, 2021	Oct. 29, 2022	Oct. 30, 2021	Jan. 29, 2022
Property, Plant and Equipment [Line Items]
Total gross property and equipment	$ 87,659,000		$ 87,659,000		$ 58,592,000
Accumulated depreciation and amortization	(30,301,000)		(30,301,000)		(21,820,000)
Property and equipment, net	57,358,000		57,358,000		36,772,000
Computers and equipment
Property, Plant and Equipment [Line Items]
Total gross property and equipment	1,206,000		1,206,000		834,000
Leasehold improvements
Property, Plant and Equipment [Line Items]
Total gross property and equipment	45,982,000		45,982,000		24,752,000
Furniture and fixtures
Property, Plant and Equipment [Line Items]
Total gross property and equipment	19,765,000		19,765,000		16,854,000
Internal-use software development costs
Property, Plant and Equipment [Line Items]
Total gross property and equipment	20,706,000		20,706,000		$ 16,152,000
Share-based payment arrangement, amount capitalized	$ 500,000	$ 0	$ 1,100,000	$ 0

Property and Equipment, Net - C

Property and Equipment, Net - Capitalized and Amortized Amounts for Internal-Use Software Development Costs (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 29, 2022	Oct. 30, 2021	Oct. 29, 2022	Oct. 30, 2021
Property, Plant and Equipment [Abstract]
Capitalized internal-use software development costs	$ 2,003	$ 1,310	$ 4,554	$ 3,226
Amortization expense	$ 934	$ 856	$ 2,911	$ 2,398

Property and Equipment, Net - I

Property and Equipment, Net - Internal-Use Software Development Costs, Net (Details) - USD ($) $ in Thousands	3 Months Ended	9 Months Ended
	Oct. 30, 2021	Oct. 30, 2021	Oct. 29, 2022	Jan. 29, 2022
Property, Plant and Equipment [Abstract]
Internal-use software development costs, net			$ 8,168	$ 6,747
Asset impairment charges, accelerated depreciation	$ 29,700	$ 29,700

Property and Equipment, Net - D

Property and Equipment, Net - Depreciation and Amortization (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 29, 2022	Oct. 30, 2021	Oct. 29, 2022	Oct. 30, 2021
Property, Plant and Equipment [Abstract]
Depreciation and amortization expense	$ 3,345	$ 512	$ 8,350	$ 8,217
Property, Plant and Equipment [Line Items]
Depreciation and amortization expense	$ 3,345	$ 512	$ 8,350	8,217
Previously Reported
Property, Plant and Equipment [Abstract]
Depreciation and amortization expense				5,819
Property, Plant and Equipment [Line Items]
Depreciation and amortization expense				$ 5,819

Leases - Narrative (Details)

Leases - Narrative (Details) - USD ($)	3 Months Ended		9 Months Ended
	Oct. 29, 2022	Oct. 30, 2021	Oct. 29, 2022	Oct. 30, 2021	Jan. 29, 2022
Lessee, Lease, Description [Line Items]
Lease modification, impairment, and related charges	$ 0	$ 1,532,000	$ 1,056,000	$ 1,532,000
Increase (decrease) in operating lease, right-of-use asset			0
Operating lease, impairment loss			$ 1,000,000
Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]	Other assets, non-current		Other assets, non-current		Other assets, non-current
Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]	Accrued expenses and other current liabilities		Accrued expenses and other current liabilities		Accrued expenses and other current liabilities
Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]	Other liabilities, non-current		Other liabilities, non-current		Other liabilities, non-current
Finance lease, right-of-use asset	$ 0		$ 0		$ 0
Finance lease, liability	$ 0		$ 0		$ 0
Minimum
Lessee, Lease, Description [Line Items]
Operating lease, remaining lease term	1 year		1 year
Maximum
Lessee, Lease, Description [Line Items]
Operating lease, remaining lease term	10 years		10 years

Leases - Operating Lease Expens

Leases - Operating Lease Expense (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 29, 2022	Oct. 30, 2021	Oct. 29, 2022	Oct. 30, 2021
Leases [Abstract]
Operating lease cost	$ 6,333	$ 6,146	$ 19,096	$ 17,686
Short-term lease cost	172	45	486	157
Sublease income	(195)	(75)	(581)	(75)
Total lease cost	$ 6,310	$ 6,116	$ 19,001	$ 17,768

Leases - Supplemental Informati

Leases - Supplemental Information Related to Operating Leases (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 29, 2022	Oct. 30, 2021	Oct. 29, 2022	Oct. 30, 2021
Leases [Abstract]
Cash paid for amounts in the measurement of operating lease liabilities—operating cash flows	$ 6,725	$ 8,418	$ 20,017	$ 18,856
Operating lease ROU assets obtained in exchange for new operating lease liabilities	$ 0	$ 19,135	$ 0	$ 19,135

Leases - Weighted Average Remai

Leases - Weighted Average Remaining Lease Term and Discount Rate (Details)	Oct. 29, 2022	Jan. 29, 2022
Leases [Abstract]
Weighted-average remaining lease term—operating leases (in years)	6 years 7 months 6 days	7 years 1 month 6 days
Weighted-average discount rate—operating leases	4.49%	4.38%

Leases - Future Minimum Lease P

Leases - Future Minimum Lease Payments (Details) $ in Thousands	Oct. 29, 2022 USD ($)
Leases [Abstract]
Remainder of 2023	$ 6,772
2024	26,853
2025	26,850
2026	19,946
2027	14,236
2028 and thereafter	56,239
Total future minimum lease payments	150,896
Less: imputed interest	(23,013)
Total operating lease liabilities	$ 127,883

Deferred Revenue and Remainin_3

Deferred Revenue and Remaining Performance Obligations - Schedule of Revenue (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 29, 2022	Oct. 30, 2021	Oct. 29, 2022	Oct. 30, 2021
Disaggregation of Revenue [Line Items]
Revenue	$ 169,800	$ 113,819	$ 465,968	$ 302,593
Subscription revenue
Disaggregation of Revenue [Line Items]
Revenue	166,555	108,981	457,083	294,743
Other revenue
Disaggregation of Revenue [Line Items]
Revenue	$ 3,245	$ 4,838	$ 8,885	$ 7,850

Deferred Revenue and Remainin_4

Deferred Revenue and Remaining Performance Obligations - Schedule of Deferred Revenue (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 29, 2022	Oct. 30, 2021	Oct. 29, 2022	Oct. 30, 2021
Contract with Customer, Liability [Roll Forward]
Deferred revenue, beginning of period	$ 354,570	$ 274,332	$ 313,686	$ 249,572
Deferred revenue, end of period	374,243	286,509	374,243	286,509
Revenue recognized in the period from beginning deferred revenue balance	$ 156,716	$ 116,586	$ 188,197	$ 127,068

Deferred Revenue and Remainin_5

Deferred Revenue and Remaining Performance Obligations - Narrative (Details) $ in Millions	Oct. 29, 2022 USD ($)
Disaggregation of Revenue [Line Items]
Remaining performance obligation, amount	$ 1,290.8
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2022-10-30
Disaggregation of Revenue [Line Items]
Remaining performance obligation, amount	$ 631.3
Remaining performance obligation, period	12 months

Commitments and Contingencies (

Commitments and Contingencies (Details) - USD ($) $ in Millions	Oct. 29, 2022	Jun. 30, 2022	Jan. 29, 2022	Nov. 17, 2021
Contractual Obligation, Fiscal Year Maturity [Abstract]
Contractual obligation, total		$ 275
Contractual obligation, year one		33
Contractual obligation, year two		42
Contractual obligation, year three		52
Contractual obligation, year four		66
Contractual obligation, year five		82
Contractual obligation, maximum offsetting amount		$ 11
Contractual obligation, offsetting amount earned	$ 0.3
Letters of credit outstanding, amount	$ 23.1		$ 23.1
Unlawful Draw Down On Letter Of Credit | Pending Litigation
Contractual Obligation, Fiscal Year Maturity [Abstract]
Loss contingency, receivable				$ 8.7

Equity - Narrative (Details)

Equity - Narrative (Details) $ in Millions	9 Months Ended
	Oct. 29, 2022 USD ($) plan shares	Oct. 30, 2021 USD ($) shares	Jan. 29, 2022 USD ($) shares	Dec. 31, 2021 shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of equity incentive plans | plan	2
Total shares of common stock reserved for future issuance	122,382,267		105,454,429
Options, grants (in shares)	0	0
Intrinsic value of shares exercised | $	$ 22.9	$ 46.9
2015 Equity Incentive Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Maximum potential capital shares added to plan (in shares)	57,631,084
Unvested early exercised shares outstanding (in shares)	28,502		138,710
2021 Employee Stock Purchase Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares reserved for future issuance, annual evergreen increase (in shares)	5,054,762
Stock options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Cost not yet recognized, amount | $	$ 6.4
Cost not yet recognized, period for recognition	1 year
Stock options | 2015 Equity Incentive Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total shares of common stock reserved for future issuance	7,045,765		8,628,071
Unvested early exercised shares outstanding, liability | $	$ 0.1		$ 0.4
RSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Cost not yet recognized, amount | $	$ 379
Cost not yet recognized, period for recognition	1 year 9 months 18 days
Award vesting period	4 years
RSUs | 2015 Equity Incentive Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total shares of common stock reserved for future issuance	17,768,415		29,452,103
ESPP | 2021 Employee Stock Purchase Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total shares of common stock reserved for future issuance	14,144,817		10,200,000	10,200,000
Cost not yet recognized, amount | $	$ 2.1
Cost not yet recognized, period for recognition	3 months 18 days
Purchase price of common stock, percent	85%
Offering period	12 months
Purchase period	6 months
Common stock purchases (in shares)	1,109,945
Proceeds from issuance of common stock | $	$ 10.3
Common Class A
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common stock, issued (in shares)	125,399,546		77,144,718
Common stock, outstanding (in shares)	125,399,546		77,144,718
Total shares of common stock reserved for future issuance				50,600,000
Common Class A | Shares available for future grants
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total shares of common stock reserved for future issuance	60,497,288		54,050,260
Shares reserved for future issuance, annual evergreen increase (in shares)	25,273,808
Common Class B
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common stock, issued (in shares)	393,473,497		428,331,442
Common stock, outstanding (in shares)	393,473,497		428,331,442
Common Class C
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common stock, issued (in shares)	0		0
Common stock, outstanding (in shares)	0		0

Equity - Schedule of Reserved S

Equity - Schedule of Reserved Shares of Common Stock for Future Issuance (Details) - shares	Oct. 29, 2022	Jan. 29, 2022	Dec. 31, 2021
Class of Stock [Line Items]
Total shares of common stock reserved for future issuance	122,382,267	105,454,429
Common Class A
Class of Stock [Line Items]
Total shares of common stock reserved for future issuance			50,600,000
Shares available for future grants | Common Class A
Class of Stock [Line Items]
Total shares of common stock reserved for future issuance	60,497,288	54,050,260
2015 Equity Incentive Plan | Stock options
Class of Stock [Line Items]
Total shares of common stock reserved for future issuance	7,045,765	8,628,071
2015 Equity Incentive Plan | RSUs
Class of Stock [Line Items]
Total shares of common stock reserved for future issuance	17,768,415	29,452,103
2021 Equity Incentive Plan | RSUs
Class of Stock [Line Items]
Total shares of common stock reserved for future issuance	22,925,982	3,123,995
2021 Employee Stock Purchase Plan | ESPP
Class of Stock [Line Items]
Total shares of common stock reserved for future issuance	14,144,817	10,200,000	10,200,000

Equity - Summary of Stock Optio

Equity - Summary of Stock Options (Details) - USD ($) $ / shares in Units, $ in Thousands	9 Months Ended	12 Months Ended
	Oct. 29, 2022	Jan. 29, 2022
Number of Shares
Balance at beginning of period (in shares)	8,628,071
Exercised (in shares)	(1,576,293)
Forfeited, canceled, or expired (in shares)	(6,013)
Balance at end of period (in shares)	7,045,765	8,628,071
Exercisable at end of period (in shares)	5,318,237
Weighted-Average Exercise Price
Balance at beginning of period (in dollars per share)	$ 3.77
Exercised (in dollars per share)	0.33
Forfeited, canceled, or expired (in dollars per share)	1.16
Balance at end of period (in dollars per share)	4.54	$ 3.77
Exercisable at end of period (in dollars per share)	$ 3.72
Stock Options, Additional Disclosures
Weighted-average remaining contractual term, outstanding	6 years 7 months 6 days	6 years 10 months 24 days
Weighted-average remaining contractual term, exercisable	6 years 2 months 12 days
Aggregate intrinsic value, outstanding	$ 55,250	$ 111,170
Aggregate intrinsic value, exercisable	$ 46,134

Equity - Summary of RSU Activit

Equity - Summary of RSU Activity (Details) - RSUs	9 Months Ended
	Oct. 29, 2022 $ / shares shares
Number of Shares
Balance at beginning of period (in shares) | shares	32,576,098
Granted (in shares) | shares	23,429,122
Vested (in shares) | shares	(10,711,083)
Forfeited (in shares) | shares	(4,599,740)
Balance at end of period (in shares) | shares	40,694,397
Weighted-Average Grant-Date Fair Value
Balance at beginning of period (in dollars per share) | $ / shares	$ 10.83
Granted (in dollars per share) | $ / shares	13.40
Vested (in dollars per share) | $ / shares	10.15
Forfeited (in dollars per share) | $ / shares	11.25
Balance at end of period (in dollars per share) | $ / shares	$ 12.44

Equity - Schedule of Weighted A

Equity - Schedule of Weighted Average Assumptions Used To Estimate The Fair Value (Details) - 2021 Employee Stock Purchase Plan - ESPP	9 Months Ended
	Oct. 29, 2022
First Purchase Period
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected volatility (in Percentage)	97.70%
Expected term (years)	6 months
Risk-free interest rate (in Percentage)	2.30%
Expected dividend yield (in Percentage)	0%
Second Purchase Period
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected volatility (in Percentage)	81%
Expected term (years)	1 year
Risk-free interest rate (in Percentage)	2.90%
Expected dividend yield (in Percentage)	0%

Equity - Summary of Stock-Based

Equity - Summary of Stock-Based Compensation Expense (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 29, 2022	Oct. 30, 2021	Oct. 29, 2022	Oct. 30, 2021
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total stock-based compensation expense	$ 45,538	$ 1,221	$ 133,490	$ 3,988
Cost of revenue
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total stock-based compensation expense	2,589	9	6,834	10
Research and development
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total stock-based compensation expense	17,928	219	45,398	550
Sales and marketing
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total stock-based compensation expense	12,292	84	41,159	381
General and administrative
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total stock-based compensation expense	12,729	909	40,099	3,047
Stock options
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total stock-based compensation expense	1,081	1,221	3,305	3,988
RSUs
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total stock-based compensation expense	41,537	0	120,888	0
ESPP
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total stock-based compensation expense	$ 2,920	$ 0	$ 9,297	$ 0

Income Taxes (Details)

Income Taxes (Details) - USD ($)	3 Months Ended		9 Months Ended
	Oct. 29, 2022	Oct. 30, 2021	Oct. 29, 2022	Oct. 30, 2021	Jan. 29, 2022
Income Tax Disclosure [Abstract]
Effective tax rate	(1.20%)	(0.10%)	(0.80%)	(0.40%)
Provision for income taxes	$ 692,000	$ 19,000	$ 1,455,000	$ 387,000
Penalties and interest accrued	$ 0		$ 0		$ 0

Net Loss Per Share, Basic and_3

Net Loss Per Share, Basic and Diluted - Schedule of Basic and Diluted Net Loss Per Share (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 29, 2022	Oct. 30, 2021	Oct. 29, 2022	Oct. 30, 2021
Numerator:
Net loss	$ (58,555)	$ (32,446)	$ (193,824)	$ (102,257)
Net loss attributable to common stockholders	$ (58,555)	$ (32,446)	$ (193,824)	$ (102,257)
Denominator:
Weighted-average shares used in computing net loss per share attributable to common stockholders, basic (in shares)	516,551,258	246,811,235	511,867,718	246,174,612
Weighted-average shares used in computing net loss per share attributable to common stockholders, diluted (in shares)	516,551,258	246,811,235	511,867,718	246,174,612
Net loss per share attributable to common stockholders, basic (in dollars per share)	$ (0.11)	$ (0.13)	$ (0.38)	$ (0.42)
Net loss per share attributable to common stockholders, diluted (in dollars per share)	$ (0.11)	$ (0.13)	$ (0.38)	$ (0.42)

Net Loss Per Share, Basic and_4

Net Loss Per Share, Basic and Diluted - Schedule of Potentially Dilutive Securities Excluded from the Computation of Diluted Net Loss per Share (Details) - shares	3 Months Ended		9 Months Ended
	Oct. 29, 2022	Oct. 30, 2021	Oct. 29, 2022	Oct. 30, 2021
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities (in shares)	47,786,984	263,462,124	47,751,913	263,462,124
Convertible preferred stock
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities (in shares)	0	205,638,256	0	205,638,256
Stock options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities (in shares)	7,045,765	9,259,852	7,045,765	9,259,852
RSUs
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities (in shares)	40,694,397	48,564,016	40,694,397	48,564,016
ESPP
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities (in shares)	46,822	0	11,751	0

Segment Information - Narrative

Segment Information - Narrative (Details)	9 Months Ended
	Oct. 29, 2022 segment
Segment Reporting [Abstract]
Number of operating segments	1
Number of reportable segments	1

Segment Information - Disaggreg

Segment Information - Disaggregation of Revenue (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Oct. 29, 2022	Oct. 30, 2021	Oct. 29, 2022	Oct. 30, 2021
Disaggregation of Revenue [Line Items]
Revenue	$ 169,800	$ 113,819	$ 465,968	$ 302,593
United States
Disaggregation of Revenue [Line Items]
Revenue	151,747	101,969	415,871	271,801
Other
Disaggregation of Revenue [Line Items]
Revenue	$ 18,053	$ 11,850	$ 50,097	$ 30,792

Segment Information - Long-live

Segment Information - Long-lived Assets by Geographic Areas (Details) - USD ($) $ in Thousands	Oct. 29, 2022	Jan. 29, 2022
Revenues from External Customers and Long-Lived Assets [Line Items]
Total long-lived assets, net	$ 175,869	$ 171,199
United States
Revenues from External Customers and Long-Lived Assets [Line Items]
Total long-lived assets, net	166,708	160,310
Other
Revenues from External Customers and Long-Lived Assets [Line Items]
Total long-lived assets, net	$ 9,161	$ 10,889